Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Drug-Related Side Effects and Adverse Reactions
go back to main search page
Accession:DOID:9006810 term browser browse the term
Definition:Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Synonyms:exact_synonym: Adverse Drug Reaction;   Adverse Drug Reactions;   Drug Side Effect;   Drug Side Effects;   Drug Toxicities;   adverse drug event;   adverse drug events;   drug toxicity;   side effects of drugs
 narrow_synonym: antidepressant-induced dizziness
 related_synonym: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to
 primary_id: MESH:D064420
 xref: EFO:0006321;   EFO:0020003



show annotations for term's descendants           Sort by:
Drug-Related Side Effects and Adverse Reactions term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 EXP
ISO
CTD Direct Evidence: marker/mechanism CTD PMID:18381794 PMID:20563569 PMID:21064136 PMID:24502637 PMID:25007187 More... NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 (ABCC1 blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:18256692 NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
JBrowse link
G ABCC12 ATP binding cassette subfamily C member 12 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr16:48,080,882...48,155,993
Ensembl chr16:48,080,882...48,156,018
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20216337 PMID:23222202 PMID:25007187 PMID:32387182 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ABCC4 ATP binding cassette subfamily C member 4 (PEL blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:23222202 NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (JR blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:21064136 PMID:32387182 NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
JBrowse link
G ACHE acetylcholinesterase (Yt blood group) EXP CTD Direct Evidence: therapeutic CTD PMID:27083141 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
JBrowse link
G ADORA1 adenosine A1 receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:15641640 NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
JBrowse link
G ADORA2A adenosine A2a receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:15641640 NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
JBrowse link
G AFM afamin EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 4:73,481,745...73,504,001
Ensembl chr 4:73,481,745...73,504,001
JBrowse link
G AHSG alpha 2-HS glycoprotein EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 3:186,613,060...186,621,318
Ensembl chr 3:186,613,060...186,621,318
JBrowse link
G ALB albumin EXP CTD Direct Evidence: marker/mechanism CTD PMID:24361871 PMID:28885000 NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
JBrowse link
G AMBP alpha-1-microglobulin/bikunin precursor EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
JBrowse link
G APOB apolipoprotein B EXP CTD Direct Evidence: marker/mechanism CTD PMID:31186542 NCBI chr 2:21,001,429...21,044,073
Ensembl chr 2:21,001,429...21,044,073
JBrowse link
G ARID5B AT-rich interaction domain 5B EXP CTD Direct Evidence: marker/mechanism CTD PMID:24712521 NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
JBrowse link
G ASS1 argininosuccinate synthase 1 ISO protein:increased expression:plasma (rat) RGD PMID:20544730 RGD:4140449 NCBI chr 9:130,444,707...130,501,274
Ensembl chr 9:130,444,961...130,501,274
JBrowse link
G ATIC 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase EXP CTD Direct Evidence: marker/mechanism CTD PMID:16947783 NCBI chr 2:215,312,059...215,368,592
Ensembl chr 2:215,311,956...215,349,773
JBrowse link
G B2M beta-2-microglobulin EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr15:44,711,517...44,718,145
Ensembl chr15:44,711,358...44,718,851
JBrowse link
G BCHE butyrylcholinesterase EXP CTD Direct Evidence: marker/mechanism CTD PMID:3111302 NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
JBrowse link
G C3 complement C3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
JBrowse link
G CACNA1H calcium voltage-gated channel subunit alpha1 H EXP CTD Direct Evidence: marker/mechanism CTD PMID:30552955 NCBI chr16:1,153,106...1,221,768
Ensembl chr16:1,153,103...1,224,169
JBrowse link
G CAMK2N1 calcium/calmodulin dependent protein kinase II inhibitor 1 IAGP associated with colon cancer RGD PMID:22020760 RGD:15097511 NCBI chr 1:20,482,391...20,486,210
Ensembl chr 1:20,482,391...20,486,210
JBrowse link
G CCL2 C-C motif chemokine ligand 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G CCL4 C-C motif chemokine ligand 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr17:36,103,827...36,105,614
Ensembl chr17:36,103,827...36,105,621
JBrowse link
G CDA cytidine deaminase IAGP DNA:SNP:cds:rs1048977|rs12726436|rs2072671 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 1:20,589,097...20,618,903
Ensembl chr 1:20,589,086...20,618,903
JBrowse link
G CES2 carboxylesterase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19931604 NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096
JBrowse link
G CLU clusterin EXP CTD Direct Evidence: marker/mechanism CTD PMID:24361871 PMID:28885000 NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
JBrowse link
G COMMD1 copper metabolism domain containing 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23583003 NCBI chr 2:61,888,391...62,136,058
Ensembl chr 2:61,888,724...62,147,247
JBrowse link
G CP ceruloplasmin EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
JBrowse link
G CSF2 colony stimulating factor 2 EXP CTD Direct Evidence: therapeutic CTD PMID:7960606 NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
JBrowse link
G CSF3 colony stimulating factor 3 EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:7692001 PMID:27737899 PMID:31557154 NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
JBrowse link
G CST3 cystatin C EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr20:23,626,706...23,637,955
Ensembl chr20:23,626,706...23,638,473
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:10445756 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP2C8 cytochrome P450 family 2 subfamily C member 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27736846 NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11740344 PMID:19925388 PMID:23104259 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23609392 NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18990727 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
G DHFR dihydrofolate reductase EXP CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
JBrowse link
G DIP2B disco interacting protein 2 homolog B EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr12:50,504,985...50,748,657
Ensembl chr12:50,504,985...50,748,657
JBrowse link
G DPYD dihydropyrimidine dehydrogenase IAGP DNA:SNP:cds:rs12119882 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 1:97,077,743...97,921,059
Ensembl chr 1:97,077,743...97,995,000
JBrowse link
G ENOSF1 enolase superfamily member 1 IAGP DNA:SNP:cds:rs699517 (human) RGD PMID:28347776 RGD:152995291 NCBI chr18:662,986...712,630
Ensembl chr18:670,318...712,662
JBrowse link
G EPHA7 EPH receptor A7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30357299 NCBI chr 6:93,240,020...93,419,559
Ensembl chr 6:93,240,020...93,419,687
JBrowse link
G EPHX2 epoxide hydrolase 2 EXP CTD Direct Evidence: therapeutic CTD PMID:26165641 NCBI chr 8:27,491,143...27,548,626
Ensembl chr 8:27,490,781...27,545,564
JBrowse link
G ERCC1 ERCC excision repair 1, endonuclease non-catalytic subunit treatment IAGP associated with Breast Neoplasms;DNA:SNP: :p.Q504K (human)
associated with Leukemia, Myeloid, Acute
RGD PMID:25495407 PMID:17197435 RGD:11252168, RGD:11252178 NCBI chr19:45,407,334...45,451,547
Ensembl chr19:45,407,334...45,478,828
JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit treatment IAGP DNA:SNP: :p.K751Q (rs13181) (human)
associated with Leukemia, Myeloid, Acute;DNA:SNPs, haplotypes: :p.D312N, p.K751Q (human)
RGD PMID:15339847 PMID:17197435 RGD:11252202, RGD:11252178 NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
JBrowse link
G FGA fibrinogen alpha chain EXP CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
JBrowse link
G FNDC3B fibronectin type III domain containing 3B EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 3:172,039,578...172,401,669
Ensembl chr 3:172,039,578...172,401,669
JBrowse link
G GATA4 GATA binding protein 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31190750 NCBI chr 8:11,676,935...11,760,002
Ensembl chr 8:11,676,959...11,760,002
JBrowse link
G GATA6 GATA binding protein 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31190750 NCBI chr18:22,169,589...22,202,528
Ensembl chr18:22,169,589...22,202,528
JBrowse link
G GC GC vitamin D binding protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
JBrowse link
G GSTA1 glutathione S-transferase alpha 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15805072 PMID:24361871 PMID:28885000 NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
JBrowse link
G HLA-B major histocompatibility complex, class I, B EXP CTD Direct Evidence: marker/mechanism CTD PMID:3084782 PMID:3133153 PMID:3157529 PMID:3437418 PMID:6770269 More... NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
JBrowse link
G HLA-C major histocompatibility complex, class I, C EXP CTD Direct Evidence: marker/mechanism CTD PMID:19629158 NCBI chr 6:31,268,749...31,272,092
Ensembl chr 6:31,268,749...31,272,130
JBrowse link
G HMGB1 high mobility group box 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27474498 NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
JBrowse link
G HMOX1 heme oxygenase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18227147 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HOMER1 homer scaffold protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:24126708 NCBI chr 5:79,372,636...79,514,134
Ensembl chr 5:79,372,636...79,514,134
JBrowse link
G HP haptoglobin EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr16:72,054,505...72,061,055
Ensembl chr16:72,054,505...72,061,055
JBrowse link
G HPX hemopexin EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617
JBrowse link
G HSPB6 heat shock protein family B (small) member 6 EXP CTD Direct Evidence: therapeutic CTD PMID:18948619 NCBI chr19:35,754,566...35,757,029
Ensembl chr19:35,754,566...35,758,079
JBrowse link
G HTR2B 5-hydroxytryptamine receptor 2B EXP CTD Direct Evidence: marker/mechanism CTD PMID:16863450 NCBI chr 2:231,108,230...231,125,042
Ensembl chr 2:231,108,230...231,125,042
JBrowse link
G IFNG interferon gamma EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G IGF1 insulin like growth factor 1 EXP CTD Direct Evidence: therapeutic CTD PMID:20064577 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
JBrowse link
G IGFBP1 insulin like growth factor binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
JBrowse link
G IGHG4 immunoglobulin heavy constant gamma 4 (G4m marker) ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr14:105,624,476...105,626,065
Ensembl chr14:105,620,506...105,626,066
JBrowse link
G IL10 interleukin 10 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL1RN interleukin 1 receptor antagonist EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
JBrowse link
G IL3 interleukin 3 EXP CTD Direct Evidence: therapeutic CTD PMID:8202718 NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
JBrowse link
G IL6 interleukin 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G KITLG KIT ligand EXP CTD Direct Evidence: therapeutic CTD PMID:1720698 NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
JBrowse link
G LCN2 lipocalin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
JBrowse link
G LTBR lymphotoxin beta receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr12:6,375,160...6,391,566
Ensembl chr12:6,375,045...6,391,571
JBrowse link
G MAPK14 mitogen-activated protein kinase 14 susceptibility IAGP associated with lung non-small cell carcinoma;DNA:SNP:3' utr, intron: (rs3804451) (human) RGD PMID:26993769 RGD:151665351 NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
JBrowse link
G MOCOS molybdenum cofactor sulfurase EXP CTD Direct Evidence: marker/mechanism CTD PMID:29935280 NCBI chr18:36,187,497...36,272,157
Ensembl chr18:36,187,497...36,272,157
JBrowse link
G MT-ATP8 mitochondrially encoded ATP synthase membrane subunit 8 IAGP ClinVar Annotator: match by term: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to ClinVar PMID:9243242 PMID:17101920 NCBI chr MT:8,366...8,572
Ensembl chr MT:8,366...8,572
JBrowse link
G MTHFR methylenetetrahydrofolate reductase EXP CTD Direct Evidence: marker/mechanism CTD PMID:15753437 PMID:16166815 PMID:17387702 PMID:17502830 PMID:18551038 More... NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
JBrowse link
G MTR 5-methyltetrahydrofolate-homocysteine methyltransferase EXP CTD Direct Evidence: marker/mechanism CTD PMID:15753437 PMID:19159907 NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
JBrowse link
G MTRR 5-methyltetrahydrofolate-homocysteine methyltransferase reductase EXP CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr 5:7,850,859...7,901,113
Ensembl chr 5:7,851,186...7,906,025
JBrowse link
G NAT1 N-acetyltransferase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:11505221 NCBI chr 8:18,170,467...18,223,689
Ensembl chr 8:18,170,477...18,223,689
JBrowse link
G NAT2 N-acetyltransferase 2 susceptibility IAGP
EXP
DNA:polymorphism: :
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:17377643 PMID:17502830 PMID:12786839 RGD:8552667 NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 EXP CTD Direct Evidence: therapeutic CTD PMID:20605904 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29802709 NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
JBrowse link
G NT5C2 5'-nucleotidase, cytosolic II EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr10:103,088,017...103,193,272
Ensembl chr10:103,087,185...103,277,605
JBrowse link
G ORM1 orosomucoid 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 9:114,323,098...114,326,479
Ensembl chr 9:114,323,098...114,326,479
JBrowse link
G PELI1 pellino E3 ubiquitin protein ligase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 2:64,092,652...64,144,420
Ensembl chr 2:64,092,652...64,144,420
JBrowse link
G PLG plasminogen EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 6:160,702,193...160,754,097
Ensembl chr 6:160,702,194...160,754,097
JBrowse link
G PLK2 polo like kinase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12897130 NCBI chr 5:58,453,982...58,460,086
Ensembl chr 5:58,453,982...58,460,139
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:19683050 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:10698006 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G REN renin EXP CTD Direct Evidence: marker/mechanism CTD PMID:8723173 NCBI chr 1:204,154,819...204,166,337
Ensembl chr 1:204,154,819...204,190,324
JBrowse link
G SERPINA1 serpin family A member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
JBrowse link
G SHMT1 serine hydroxymethyltransferase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr17:18,327,873...18,363,550
Ensembl chr17:18,327,873...18,363,550
JBrowse link
G SLC19A1 solute carrier family 19 member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr21:45,502,517...45,563,025
Ensembl chr21:45,493,572...45,573,365
JBrowse link
G SLC22A7 solute carrier family 22 member 7 IAGP DNA:SNP:cds:rs2270860|rs4149178 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
JBrowse link
G SLC34A2 solute carrier family 34 member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 4:25,655,851...25,678,748
Ensembl chr 4:25,648,011...25,678,748
JBrowse link
G SLCO1B1 solute carrier organic anion transporter family member 1B1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21387541 NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
JBrowse link
G SLCO2A1 solute carrier organic anion transporter family member 2A1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 3:133,932,701...134,029,925
Ensembl chr 3:133,932,701...134,052,184
JBrowse link
G SOD1 superoxide dismutase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G SPP1 secreted phosphoprotein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
JBrowse link
G TCN2 transcobalamin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15753437 NCBI chr22:30,607,174...30,627,271
Ensembl chr22:30,607,003...30,627,271
JBrowse link
G TF transferrin EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
JBrowse link
G THBD thrombomodulin EXP CTD Direct Evidence: therapeutic CTD PMID:27474498 NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
JBrowse link
G TLR1 toll like receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr 4:38,787,569...38,805,644
Ensembl chr 4:38,790,677...38,856,817
JBrowse link
G TLR2 toll like receptor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18466103 PMID:31557154 NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
JBrowse link
G TNF tumor necrosis factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TOP1 DNA topoisomerase I EXP CTD Direct Evidence: marker/mechanism CTD PMID:19931604 NCBI chr20:41,028,822...41,124,487
Ensembl chr20:41,028,822...41,124,487
JBrowse link
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:9369336 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TTR transthyretin EXP CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
JBrowse link
G TXN thioredoxin ISO CTD Direct Evidence: therapeutic CTD PMID:11462148 NCBI chr 9:110,243,810...110,256,507
Ensembl chr 9:110,243,810...110,256,507
JBrowse link
G TYMS thymidylate synthetase EXP
IAGP
CTD Direct Evidence: marker/mechanism
DNA:SNP:cds:rs2853741 (human)
CTD
RGD
PMID:19648163 PMID:21064136 PMID:25007187 PMID:26077125 PMID:28347776 RGD:152995291 NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
JBrowse link
G UGT1A1 UDP glucuronosyltransferase family 1 member A1 EXP CTD Direct Evidence: therapeutic CTD PMID:19931604 NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
JBrowse link
G UMPS uridine monophosphate synthetase IAGP DNA:SNP:cds:rs2279199|rs4678145 (human) RGD PMID:28347776 RGD:152995291 NCBI chr 3:124,730,452...124,749,273
Ensembl chr 3:124,730,433...124,749,273
JBrowse link
G VEGFA vascular endothelial growth factor A EXP CTD Direct Evidence: marker/mechanism CTD PMID:31068094 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VKORC1 vitamin K epoxide reductase complex subunit 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26445138 NCBI chr16:31,090,854...31,094,797
Ensembl chr16:31,090,842...31,095,980
JBrowse link
abacavir allergy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G HCP5 HLA complex P5 IAGP ClinVar Annotator: match by term: Abacavir hypersensitivity ClinVar PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 More... NCBI chr 6:31,463,180...31,465,809
Ensembl chr 6:31,463,170...31,478,936
JBrowse link
G HLA-B major histocompatibility complex, class I, B IAGP ClinVar Annotator: match by term: Abacavir hypersensitivity ClinVar PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 More... NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
JBrowse link
Anthracycline-induced Cardiotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 susceptibility IAGP DNA:missense mutation:cds:p.G671V (human) RGD PMID:16330681 RGD:11041175 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ACVR2B activin A receptor type 2B treatment IMP human construct in mouse model RGD PMID:30765322 RGD:329849112 NCBI chr 3:38,453,890...38,493,142
Ensembl chr 3:38,453,890...38,493,142
JBrowse link
G CAPN2 calpain 2 treatment ISO RGD PMID:25634181 RGD:13792617 NCBI chr 1:223,701,597...223,776,018
Ensembl chr 1:223,701,593...223,776,018
JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit IAGP associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human) RGD PMID:24284041 RGD:11252190 NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
JBrowse link
aspirin-induced respiratory disease term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CACNG6 calcium voltage-gated channel auxiliary subunit gamma 6 susceptibility IAGP DNA:SNP,haplotype:rs192808(human) RGD PMID:20860846 RGD:13524562 NCBI chr19:53,991,149...54,012,666
Ensembl chr19:53,991,637...54,012,666
JBrowse link
G CCR3 C-C motif chemokine receptor 3 IEP
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:20485159 PMID:20022477 RGD:4145619 NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
JBrowse link
G CYSLTR1 cysteinyl leukotriene receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16502481 PMID:17641958 PMID:20485159 NCBI chr  X:78,271,468...78,327,611
Ensembl chr  X:78,271,468...78,327,691
JBrowse link
G CYSLTR2 cysteinyl leukotriene receptor 2 IAGP
EXP
DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16502481 PMID:20485159 PMID:15970796 RGD:5144000 NCBI chr13:48,653,929...48,711,226
Ensembl chr13:48,653,711...48,711,226
JBrowse link
G FANCC FA complementation group C IAGP DNA:haplotype::rs4647416(human) RGD PMID:21670957 RGD:11045795 NCBI chr 9:95,099,054...95,317,709
Ensembl chr 9:95,099,054...95,426,796
JBrowse link
G HLA-DPB1 major histocompatibility complex, class II, DP beta 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,990...33,089,696
JBrowse link
G HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 susceptibility IAGP RGD PMID:25975240 RGD:11074090 NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
JBrowse link
G HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 susceptibility IAGP RGD PMID:25975240 RGD:11074090 NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
JBrowse link
G HLA-DRB1 major histocompatibility complex, class II, DR beta 1 susceptibility IAGP RGD PMID:25975240 RGD:11074090 NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
JBrowse link
G HLA-DRB3 major histocompatibility complex, class II, DR beta 3 susceptibility IAGP RGD PMID:25975240 RGD:11074090
G HLA-DRB4 major histocompatibility complex, class II, DR beta 4 susceptibility IAGP RGD PMID:25975240 RGD:11074090
G IL4 interleukin 4 susceptibility IAGP DNA:SNPs:promoter,5'UTR,intron:multiple RGD PMID:20921925 RGD:11528633 NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
JBrowse link
G LOC109286563 TBX21 promoter region IAGP ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to ClinVar PMID:15806396 NCBI chr17:47,731,244...47,733,594 JBrowse link
G LTC4S leukotriene C4 synthase EXP CTD Direct Evidence: marker/mechanism CTD PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
JBrowse link
G MS4A2 membrane spanning 4-domains A2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr11:60,088,259...60,098,467
Ensembl chr11:60,088,261...60,098,467
JBrowse link
G POSTN periostin EXP CTD Direct Evidence: marker/mechanism CTD PMID:18391768 NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
JBrowse link
G PTGDR2 prostaglandin D2 receptor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr11:60,850,933...60,855,950
Ensembl chr11:60,850,933...60,855,950
JBrowse link
G PTGER2 prostaglandin E receptor 2 IAGP
EXP
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
PMID:15496426 PMID:16502481 NCBI chr14:52,314,312...52,328,598
Ensembl chr14:52,314,305...52,328,598
JBrowse link
G PTGIR prostaglandin I2 receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr19:46,610,687...46,625,089
Ensembl chr19:46,620,468...46,625,089
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 IEP
EXP
protein:increased expression:mast cell
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16502481 PMID:20485159 PMID:9487340 RGD:5143936 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G TAP2 transporter 2, ATP binding cassette subfamily B member IAGP RGD PMID:21796142 RGD:5147839 NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
JBrowse link
G TBX21 T-box transcription factor 21 IAGP
EXP
ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
PMID:15806396 PMID:16502481 NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
JBrowse link
G TBXA2R thromboxane A2 receptor susceptibility IAGP
EXP
DNA:polymorphism: :795T>C (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16502481 PMID:20485159 PMID:15898979 RGD:11059537 NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
JBrowse link
asthma, nasal polyps, and aspirin intolerance term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX15 arachidonate 15-lipoxygenase IAGP ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance ClinVar PMID:17959182 PMID:21558275 PMID:30643255 NCBI chr17:4,630,919...4,641,678
Ensembl chr17:4,630,919...4,642,294
JBrowse link
G LOC109286563 TBX21 promoter region IAGP ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance ClinVar PMID:25741868 NCBI chr17:47,731,244...47,733,594 JBrowse link
G LOC130061064 ATAC-STARR-seq lymphoblastoid silent region 8640 IAGP ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance ClinVar PMID:25741868 NCBI chr17:47,733,625...47,733,794 JBrowse link
G PTGER2 prostaglandin E receptor 2 susceptibility IAGP
EXP
CTD Direct Evidence: marker/mechanism OMIM
CTD
NCBI chr14:52,314,312...52,328,598
Ensembl chr14:52,314,305...52,328,598
JBrowse link
G TBX21 T-box transcription factor 21 susceptibility EXP
IAGP
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance
CTD
ClinVar
OMIM
PMID:25741868 NCBI chr17:47,733,236...47,746,122
Ensembl chr17:47,733,236...47,746,122
JBrowse link
Cardiotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACACB acetyl-CoA carboxylase beta ISO mRNA, protein:increased expression:heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226
JBrowse link
G AGT angiotensinogen EXP CTD Direct Evidence: marker/mechanism CTD PMID:33676887 NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
JBrowse link
G BCHE butyrylcholinesterase EXP CTD Direct Evidence: therapeutic CTD PMID:26145887 NCBI chr 3:165,772,904...165,837,423
Ensembl chr 3:165,772,904...165,837,462
JBrowse link
G BMP2 bone morphogenetic protein 2 EXP CTD Direct Evidence: therapeutic CTD PMID:29800642 NCBI chr20:6,767,686...6,780,246
Ensembl chr20:6,767,686...6,780,246
JBrowse link
G CAT catalase EXP CTD Direct Evidence: therapeutic CTD PMID:35792220 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CCL2 C-C motif chemokine ligand 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G CPT1A carnitine palmitoyltransferase 1A ISO mRNA, protein:decreased expression:heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
JBrowse link
G CSF1 colony stimulating factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32068018 NCBI chr 1:109,910,506...109,930,992
Ensembl chr 1:109,910,242...109,930,992
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G FAS Fas cell surface death receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:34713381 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G FASLG Fas ligand EXP
ISO
CTD Direct Evidence: marker/mechanism CTD PMID:34713381 NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
JBrowse link
G FTO FTO alpha-ketoglutarate dependent dioxygenase ISO DNA:hypermethylation:promoter RGD PMID:35462195 RGD:329951017 NCBI chr16:53,703,963...54,121,941
Ensembl chr16:53,701,692...54,158,512
JBrowse link
G HBEGF heparin binding EGF like growth factor EXP CTD Direct Evidence: therapeutic CTD PMID:29305325 NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
JBrowse link
G IL1B interleukin 1 beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:32068018 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G METTL14 methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:34648132 NCBI chr 4:118,685,392...118,715,430
Ensembl chr 4:118,685,392...118,715,433
JBrowse link
G MIR143 microRNA 143 ameliorates ISO RGD PMID:32170053 RGD:155883163 NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023
JBrowse link
G MIR208A microRNA 208a EXP CTD Direct Evidence: marker/mechanism CTD PMID:26454886 NCBI chr14:23,388,596...23,388,666
Ensembl chr14:23,388,596...23,388,666
JBrowse link
G MLYCD malonyl-CoA decarboxylase ISO protein:increased expression:heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr16:83,899,115...83,927,031
Ensembl chr16:83,899,115...83,951,445
JBrowse link
G NOS3 nitric oxide synthase 3 treatment IAGP associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human) RGD PMID:26345518 RGD:11533645 NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
JBrowse link
G NPPB natriuretic peptide B EXP CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
JBrowse link
G NRG1 neuregulin 1 EXP CTD Direct Evidence: therapeutic CTD PMID:29305325 NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
JBrowse link
G PRKAA2 protein kinase AMP-activated catalytic subunit alpha 2 ISO protein:decreased expression:serum, heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
JBrowse link
G RAC1 Rac family small GTPase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28710503 NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967
JBrowse link
G RARG retinoic acid receptor gamma EXP CTD Direct Evidence: marker/mechanism CTD PMID:26237429 NCBI chr12:53,210,569...53,232,209
Ensembl chr12:53,210,567...53,232,980
JBrowse link
G RNF10 ring finger protein 10 EXP CTD Direct Evidence: therapeutic CTD PMID:36740146 NCBI chr12:120,534,356...120,577,588
Ensembl chr12:120,533,480...120,577,588
JBrowse link
G SIRT6 sirtuin 6 EXP CTD Direct Evidence: therapeutic CTD PMID:34713381 NCBI chr19:4,174,109...4,182,563
Ensembl chr19:4,174,109...4,182,566
JBrowse link
G TLR2 toll like receptor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,070...153,706,260
JBrowse link
G TNF tumor necrosis factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:29959987 PMID:32068018 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TP53 tumor protein p53 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD PMID:30009776 PMID:34713381 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
Chemical and Drug Induced Liver Injury term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AASS aminoadipate-semialdehyde synthase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:122,073,549...122,144,249
Ensembl chr 7:122,064,583...122,144,308
JBrowse link
G ABCB1 ATP binding cassette subfamily B member 1 severity
susceptibility
ISO
IAGP
EXP
DNA:SNP::2677G>T/A(rs2032582)(human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:20623750 PMID:26134275 PMID:26134275 PMID:27296832 RGD:11041130, RGD:14700895 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ABCB11 ATP binding cassette subfamily B member 11 severity IAGP DNA:SNP: :rs2287616(human) RGD PMID:27293027 RGD:14402413 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324
JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 (ABCC1 blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 susceptibility EXP
IAGP
IEP
CTD Direct Evidence: marker/mechanism
DNA:polymorphism:promoter:-24C>T(human)
CTD
RGD
PMID:18381794 PMID:18466103 PMID:17241877 PMID:25196354 RGD:14700814, RGD:14700812 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ABI1 abl interactor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:26,746,596...26,860,958
Ensembl chr10:26,746,593...26,861,087
JBrowse link
G ACE angiotensin I converting enzyme ISO mRNA:increased expression:liver (rat) RGD PMID:25143335 RGD:25671447 NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
JBrowse link
G ACOX3 acyl-CoA oxidase 3, pristanoyl EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:8,355,305...8,440,723
Ensembl chr 4:8,366,282...8,440,723
JBrowse link
G ACSL1 acyl-CoA synthetase long chain family member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:184,755,595...184,826,594
Ensembl chr 4:184,755,595...184,826,818
JBrowse link
G ACTB actin beta ISO
EXP
mRNA:increased expression:liver
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:25231249 PMID:22563491 RGD:9587759 NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
JBrowse link
G ACTN4 actinin alpha 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:38,647,649...38,731,589
Ensembl chr19:38,647,649...38,731,589
JBrowse link
G ACTR3 actin related protein 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:113,889,934...113,962,596
Ensembl chr 2:113,890,063...113,962,596
JBrowse link
G ADA adenosine deaminase ISO protein:increased expression:liver RGD PMID:21161045 RGD:5128859 NCBI chr20:44,619,522...44,651,699
Ensembl chr20:44,584,896...44,652,252
JBrowse link
G ADAM8 ADAM metallopeptidase domain 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:24646716 NCBI chr10:133,262,423...133,276,868
Ensembl chr10:133,262,420...133,276,868
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing EXP CTD Direct Evidence: therapeutic CTD PMID:20709802 NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
JBrowse link
G ADIPOR2 adiponectin receptor 2 severity ISO associated with obesity, LPS;mRNA:decreased expression:liver (rat) RGD PMID:23838384 RGD:8695926 NCBI chr12:1,691,070...1,788,674
Ensembl chr12:1,688,574...1,788,674
JBrowse link
G ADORA2B adenosine A2b receptor EXP CTD Direct Evidence: therapeutic CTD PMID:35292334 NCBI chr17:15,850,362...15,975,746
Ensembl chr17:15,945,130...15,975,746
JBrowse link
G AGT angiotensinogen EXP CTD Direct Evidence: marker/mechanism CTD PMID:29499335 NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
JBrowse link
G AHR aryl hydrocarbon receptor EXP
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
mRNA:decreased expression:liver (rat)
CTD
RGD
PMID:21890736 PMID:34848246 PMID:28959666 RGD:401794432 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G AIFM1 apoptosis inducing factor mitochondria associated 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25743375 NCBI chr  X:130,129,362...130,165,841
Ensembl chr  X:130,124,666...130,165,879
JBrowse link
G AK4 adenylate kinase 4 ISO protein:increased expression:liver (rat) RGD PMID:16538043 RGD:2301096 NCBI chr 1:65,147,552...65,232,145
Ensembl chr 1:65,147,549...65,232,145
JBrowse link
G AKR1A1 aldo-keto reductase family 1 member A1 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:32805337 PMID:29763686 RGD:27226688 NCBI chr 1:45,550,826...45,570,049
Ensembl chr 1:45,550,543...45,570,049
JBrowse link
G ALB albumin treatment EXP
ISO
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:18779383 PMID:22310181 PMID:27567545 RGD:14694844 NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
JBrowse link
G ALDH1L2 aldehyde dehydrogenase 1 family member L2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:105,019,790...105,084,458
Ensembl chr12:105,019,784...105,107,643
JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member severity
susceptibility
ISO protein:increased expression:liver
DNA:deletion:exon 3 (mouse)
RGD PMID:21138988 PMID:30121625 PMID:24492981 RGD:7241599, RGD:15036810, RGD:14975148 NCBI chr12:111,766,933...111,817,532
Ensembl chr12:111,766,887...111,817,532
JBrowse link
G ALDH9A1 aldehyde dehydrogenase 9 family member A1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:165,662,216...165,698,562
Ensembl chr 1:165,662,216...165,698,562
JBrowse link
G ALDOB aldolase, fructose-bisphosphate B EXP CTD Direct Evidence: marker/mechanism CTD PMID:16115720 NCBI chr 9:101,420,560...101,435,774
Ensembl chr 9:101,420,560...101,449,664
JBrowse link
G AMBP alpha-1-microglobulin/bikunin precursor EXP CTD Direct Evidence: marker/mechanism CTD PMID:18779383 NCBI chr 9:114,060,127...114,078,300
Ensembl chr 9:114,060,127...114,078,328
JBrowse link
G ANXA2 annexin A2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr15:60,347,151...60,397,986
Ensembl chr15:60,347,134...60,402,883
JBrowse link
G ANXA6 annexin A6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:151,100,706...151,157,779
Ensembl chr 5:151,100,706...151,157,815
JBrowse link
G APOA1 apolipoprotein A1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
JBrowse link
G APOE apolipoprotein E EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
JBrowse link
G APOH apolipoprotein H ISO
EXP
mRNA:increased expression:plasma:
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:16099942 PMID:23288050 RGD:10054107 NCBI chr17:66,212,033...66,229,415
Ensembl chr17:66,212,033...66,256,525
JBrowse link
G ARG1 arginase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22872058 NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator EXP CTD Direct Evidence: marker/mechanism CTD PMID:20935161 NCBI chr 1:150,809,713...150,876,599
Ensembl chr 1:150,809,713...150,876,708
JBrowse link
G ATG5 autophagy related 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22491424 NCBI chr 6:106,184,476...106,325,760
Ensembl chr 6:106,045,423...106,325,791
JBrowse link
G ATOH8 atonal bHLH transcription factor 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:85,753,991...85,791,383
Ensembl chr 2:85,751,344...85,791,383
JBrowse link
G ATP6V1D ATPase H+ transporting V1 subunit D EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:67,337,872...67,359,804
Ensembl chr14:67,294,371...67,360,265
JBrowse link
G BAD BCL2 associated agonist of cell death treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr11:64,269,828...64,284,704
Ensembl chr11:64,269,830...64,284,704
JBrowse link
G BAX BCL2 associated X, apoptosis regulator EXP CTD Direct Evidence: marker/mechanism CTD PMID:17906064 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BDH1 3-hydroxybutyrate dehydrogenase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:197,509,783...197,573,343
Ensembl chr 3:197,509,783...197,573,323
JBrowse link
G BDKRB2 bradykinin receptor B2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30685357 NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
JBrowse link
G BLVRB biliverdin reductase B EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:40,447,768...40,465,745
Ensembl chr19:40,447,765...40,465,764
JBrowse link
G BMAL1 basic helix-loop-helix ARNT like 1 EXP CTD Direct Evidence: therapeutic CTD PMID:36602574 NCBI chr11:13,276,652...13,387,266
Ensembl chr11:13,276,652...13,387,266
JBrowse link
G BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:220,057,482...220,089,788
Ensembl chr 1:220,057,482...220,090,462
JBrowse link
G BRD4 bromodomain containing 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:15,235,519...15,332,539
Ensembl chr19:15,235,519...15,332,545
JBrowse link
G BTD biotinidase EXP CTD Direct Evidence: marker/mechanism CTD PMID:15469856 NCBI chr 3:15,601,361...15,722,516
Ensembl chr 3:15,601,341...15,722,311
JBrowse link
G C3 complement C3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
JBrowse link
G CA3 carbonic anhydrase 3 ISO
EXP
CTD Direct Evidence: marker/mechanism CTD PMID:25226513 PMID:25231249 NCBI chr 8:85,438,859...85,449,040
Ensembl chr 8:85,373,436...85,449,040
JBrowse link
G CABP1 calcium binding protein 1 ISO protein:increased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr12:120,640,626...120,680,866
Ensembl chr12:120,640,626...120,667,324
JBrowse link
G CADPS2 calcium dependent secretion activator 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 7:122,318,411...122,886,460
Ensembl chr 7:122,318,411...122,886,759
JBrowse link
G CANX calnexin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:179,678,656...179,731,641
Ensembl chr 5:179,678,628...179,731,641
JBrowse link
G CAP1 cyclase associated actin cytoskeleton regulatory protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:40,040,240...40,072,648
Ensembl chr 1:40,040,233...40,072,649
JBrowse link
G CASP8 caspase 8 treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G CAST calpastatin ISO RGD PMID:16871587 RGD:5683869 NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,525,267...96,779,595
Ensembl chr 5:96,525,267...96,779,595
JBrowse link
G CAT catalase EXP
ISO
CTD Direct Evidence: marker/mechanism
protein:decreased expression:liver
CTD
RGD
PMID:20623750 PMID:25231249 PMID:21138988 RGD:7241599 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CCDC80 coiled-coil domain containing 80 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:112,596,797...112,641,143
Ensembl chr 3:112,596,797...112,649,530
JBrowse link
G CCL2 C-C motif chemokine ligand 2 treatment EXP
ISO
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:20623750 PMID:21813474 PMID:30663942 RGD:14995466, RGD:14995458 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G CCR2 C-C motif chemokine receptor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 3:46,354,111...46,360,940
Ensembl chr 3:46,353,864...46,360,940
JBrowse link
G CCR5 C-C motif chemokine receptor 5 susceptibility ISO acetaminophen RGD PMID:24770590 RGD:14401733 NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
JBrowse link
G CCT3 chaperonin containing TCP1 subunit 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:156,308,968...156,338,292
Ensembl chr 1:156,308,968...156,367,873
JBrowse link
G CCT5 chaperonin containing TCP1 subunit 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:10,249,921...10,266,412
Ensembl chr 5:10,249,929...10,266,389
JBrowse link
G CDC25B cell division cycle 25B EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr20:3,786,951...3,806,115
Ensembl chr20:3,786,772...3,806,121
JBrowse link
G CDS1 CDP-diacylglycerol synthase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:84,583,127...84,651,334
Ensembl chr 4:84,583,127...84,651,334
JBrowse link
G CELA1 chymotrypsin like elastase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:51,328,442...51,346,679
Ensembl chr12:51,328,442...51,346,679
JBrowse link
G CFAP20 cilia and flagella associated protein 20 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr16:58,113,592...58,129,381
Ensembl chr16:58,113,592...58,129,381
JBrowse link
G CFH complement factor H EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:196,652,043...196,747,504
Ensembl chr 1:196,651,754...196,752,476
JBrowse link
G CHRM3 cholinergic receptor muscarinic 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20197374 NCBI chr 1:239,386,568...239,915,450
Ensembl chr 1:239,386,565...239,915,452
JBrowse link
G CKB creatine kinase B EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr14:103,519,667...103,522,830
Ensembl chr14:103,519,667...103,522,833
JBrowse link
G CLU clusterin EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
JBrowse link
G COL14A1 collagen type XIV alpha 1 chain EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 8:120,124,454...120,373,573
Ensembl chr 8:120,059,780...120,373,573
JBrowse link
G COL3A1 collagen type III alpha 1 chain EXP CTD Direct Evidence: marker/mechanism CTD PMID:16679477 NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
JBrowse link
G COMT catechol-O-methyltransferase ISO protein:decreased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
JBrowse link
G COQ9 coenzyme Q9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr16:57,447,479...57,461,270
Ensembl chr16:57,447,425...57,461,270
JBrowse link
G CP ceruloplasmin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
JBrowse link
G CPB2 carboxypeptidase B2 ISO mRNA,protein:increased expression,increased activity:liver,plasma RGD PMID:19386599 RGD:7243112 NCBI chr13:46,053,186...46,105,033
Ensembl chr13:46,053,186...46,105,033
JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:210,477,685...210,679,107
Ensembl chr 2:210,477,682...210,679,107
JBrowse link
G CPT1A carnitine palmitoyltransferase 1A ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr11:68,754,620...68,844,277
Ensembl chr11:68,754,620...68,844,410
JBrowse link
G CRP C-reactive protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
JBrowse link
G CSF3 colony stimulating factor 3 EXP CTD Direct Evidence: therapeutic CTD PMID:20005281 NCBI chr17:40,015,440...40,017,813
Ensembl chr17:40,015,361...40,017,813
JBrowse link
G CTNNB1 catenin beta 1 EXP CTD Direct Evidence: therapeutic CTD PMID:19679878 NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
JBrowse link
G CTSE cathepsin E EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:206,009,264...206,023,895
Ensembl chr 1:206,008,535...206,023,909
JBrowse link
G CXCL1 C-X-C motif chemokine ligand 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16118408 NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 EXP CTD Direct Evidence: therapeutic CTD PMID:11739529 NCBI chr 4:76,021,118...76,023,497
Ensembl chr 4:76,021,118...76,023,497
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28762043 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
JBrowse link
G CYP27B1 cytochrome P450 family 27 subfamily B member 1 ISO mRNA, protein:decreased expression:kidney (mouse) RGD PMID:26476181 RGD:25671412 NCBI chr12:57,762,334...57,767,078
Ensembl chr12:57,762,334...57,768,986
JBrowse link
G CYP2A6 cytochrome P450 family 2 subfamily A member 6 EXP
ISO
CTD Direct Evidence: marker/mechanism
CTD Direct Evidence: therapeutic
CTD PMID:21741958 PMID:23628428 NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28762043 PMID:33814510 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
JBrowse link
G CYP2C18 cytochrome P450 family 2 subfamily C member 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr10:94,683,729...94,736,190
Ensembl chr10:94,683,729...94,736,190
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 EXP CTD Direct Evidence: marker/mechanism CTD PMID:12963435 PMID:28762043 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:14971821 PMID:21741958 PMID:28762043 PMID:33814510 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 IAGP DNA:hypermethylation:promoter RGD PMID:27490558 RGD:14700879 NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 treatment EXP
ISO
IAGP
IMP
CTD Direct Evidence: marker/mechanism
DNA:hypermethylation:promoter
associated with Endotoxemia
CTD
RGD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:28762043 PMID:27960551 More... RGD:14700901, RGD:14700879, RGD:14700878, RGD:14700873, RGD:14700872 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28762043 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G CYP8B1 cytochrome P450 family 8 subfamily B member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25448281 NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898
JBrowse link
G DBT dihydrolipoamide branched chain transacylase E2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:100,186,919...100,249,834
Ensembl chr 1:100,186,919...100,249,834
JBrowse link
G DDB1 damage specific DNA binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:61,299,451...61,333,105
Ensembl chr11:61,299,451...61,342,596
JBrowse link
G DGAT2 diacylglycerol O-acyltransferase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr11:75,768,778...75,801,534
Ensembl chr11:75,759,512...75,801,535
JBrowse link
G DHFR dihydrofolate reductase EXP CTD Direct Evidence: marker/mechanism CTD PMID:19648163 NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
JBrowse link
G DHRS7 dehydrogenase/reductase 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:60,144,119...60,169,889
Ensembl chr14:60,144,119...60,169,856
JBrowse link
G DLAT dihydrolipoamide S-acetyltransferase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:112,025,408...112,064,404
Ensembl chr11:112,025,033...112,064,404
JBrowse link
G DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 7:108,569,874...108,574,850
Ensembl chr 7:108,569,867...108,574,850
JBrowse link
G DNAJC12 DnaJ heat shock protein family (Hsp40) member C12 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr10:67,796,669...67,838,188
Ensembl chr10:67,796,669...67,838,188
JBrowse link
G DSC2 desmocollin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr18:31,058,840...31,102,421
Ensembl chr18:31,058,840...31,102,522
JBrowse link
G E2F1 E2F transcription factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
JBrowse link
G ECHDC1 ethylmalonyl-CoA decarboxylase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 6:127,288,712...127,343,609
Ensembl chr 6:127,288,712...127,343,609
JBrowse link
G ECHS1 enoyl-CoA hydratase, short chain 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:133,362,485...133,373,354
Ensembl chr10:133,362,485...133,373,354
JBrowse link
G EDEM1 ER degradation enhancing alpha-mannosidase like protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:5,187,707...5,219,958
Ensembl chr 3:5,187,646...5,219,958
JBrowse link
G EIF2AK1 eukaryotic translation initiation factor 2 alpha kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25411909 NCBI chr 7:6,022,247...6,059,175
Ensembl chr 7:6,022,247...6,059,175
JBrowse link
G EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:70,404,145...70,428,618
Ensembl chr10:70,404,145...70,428,618
JBrowse link
G ENDOG endonuclease G ISO protein:decreased expression:mitochondrion: RGD PMID:22509279 RGD:9685364 NCBI chr 9:128,818,500...128,822,676
Ensembl chr 9:128,818,500...128,822,676
JBrowse link
G ENG endoglin ISO protein:increased expression:liver (rat) RGD PMID:21146604 RGD:7257529 NCBI chr 9:127,815,016...127,854,658
Ensembl chr 9:127,815,013...127,854,658
JBrowse link
G ENO1 enolase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:25231249 NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
JBrowse link
G ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 ISO protein:increased activity:serum: RGD PMID:17850827 RGD:9685426 NCBI chr 8:119,557,086...119,673,390
Ensembl chr 8:119,557,086...119,673,453
JBrowse link
G EPHX1 epoxide hydrolase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
JBrowse link
G ERLEC1 endoplasmic reticulum lectin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 2:53,787,044...53,818,796
Ensembl chr 2:53,787,009...53,833,038
JBrowse link
G ERN1 endoplasmic reticulum to nucleus signaling 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30538632 NCBI chr17:64,039,142...64,130,144
Ensembl chr17:64,039,080...64,130,819
JBrowse link
G F13A1 coagulation factor XIII A chain ISO RGD PMID:22019897 RGD:11041813 NCBI chr 6:6,144,084...6,320,662
Ensembl chr 6:6,144,084...6,321,013
JBrowse link
G F2RL3 F2R like thrombin or trypsin receptor 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr19:16,888,999...16,892,606
Ensembl chr19:16,888,999...16,892,606
JBrowse link
G F3 coagulation factor III, tissue factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:22407844 NCBI chr 1:94,529,173...94,541,759
Ensembl chr 1:94,529,173...94,541,759
JBrowse link
G FADD Fas associated via death domain treatment ISO RGD PMID:26062544 PMID:25447754 RGD:11341803, RGD:10053709 NCBI chr11:70,203,296...70,207,390
Ensembl chr11:70,203,296...70,207,390
JBrowse link
G FADS1 fatty acid desaturase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:61,799,627...61,817,003
Ensembl chr11:61,799,627...61,829,318
JBrowse link
G FADS2 fatty acid desaturase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:61,816,203...61,867,354
Ensembl chr11:61,792,980...61,867,354
JBrowse link
G FAS Fas cell surface death receptor ISO protein:increased expression:liver (rat) RGD PMID:16831245 RGD:8662853 NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
JBrowse link
G FASN fatty acid synthase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
JBrowse link
G FCMR Fc mu receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:206,903,317...206,923,196
Ensembl chr 1:206,903,317...206,923,247
JBrowse link
G FGA fibrinogen alpha chain EXP CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr 4:154,583,126...154,590,742
Ensembl chr 4:154,583,126...154,590,742
JBrowse link
G FGF21 fibroblast growth factor 21 severity ISO mRNA:increased expression:liver (rat) RGD PMID:29883717 RGD:15045603 NCBI chr19:48,755,524...48,758,330
Ensembl chr19:48,755,524...48,758,333
JBrowse link
G FLT1 fms related receptor tyrosine kinase 1 EXP CTD Direct Evidence: therapeutic CTD PMID:21135413 NCBI chr13:28,300,346...28,495,128
Ensembl chr13:28,300,346...28,495,145
JBrowse link
G FMO3 flavin containing dimethylaniline monoxygenase 3 EXP CTD Direct Evidence: therapeutic CTD PMID:24973094 NCBI chr 1:171,090,905...171,117,819
Ensembl chr 1:171,090,901...171,117,819
JBrowse link
G FTL ferritin light chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr19:48,965,309...48,966,879
Ensembl chr19:48,965,309...48,966,879
JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 ISO mRNA:decreased expression:liver (mouse) RGD PMID:28189721 RGD:14695531 NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
JBrowse link
G G6PD glucose-6-phosphate dehydrogenase treatment ISO RGD PMID:21864513 RGD:10449168 NCBI chr  X:154,531,390...154,547,569
Ensembl chr  X:154,517,825...154,547,572
JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
JBrowse link
G GANAB glucosidase II alpha subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:62,624,829...62,646,613
Ensembl chr11:62,624,826...62,646,726
JBrowse link
G GC GC vitamin D binding protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit ISO
EXP
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:19481141 PMID:17573345 RGD:10402383 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
JBrowse link
G GDA guanine deaminase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:72,114,608...72,259,869
Ensembl chr 9:72,114,595...72,257,193
JBrowse link
G GDI1 GDP dissociation inhibitor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:154,437,154...154,443,467
Ensembl chr  X:154,436,913...154,443,467
JBrowse link
G GFER growth factor, augmenter of liver regeneration treatment IDA
ISO
RGD PMID:22033404 PMID:15968720 RGD:9685722, RGD:9685727 NCBI chr16:1,984,193...1,987,749
Ensembl chr16:1,984,193...1,987,749
JBrowse link
G GGH gamma-glutamyl hydrolase EXP CTD Direct Evidence: marker/mechanism CTD PMID:21219404 NCBI chr 8:63,015,079...63,038,806
Ensembl chr 8:63,014,881...63,039,407
JBrowse link
G GGT1 gamma-glutamyltransferase 1 ISO RGD PMID:10934156 RGD:14701049 NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005
JBrowse link
G GLUD1 glutamate dehydrogenase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:33483742 NCBI chr10:87,050,202...87,094,843
Ensembl chr10:87,050,202...87,094,843
JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624
JBrowse link
G GPD1 glycerol-3-phosphate dehydrogenase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:50,104,008...50,111,313
Ensembl chr12:50,103,982...50,111,313
JBrowse link
G GPT glutamic--pyruvic transaminase treatment EXP
ISO
CTD Direct Evidence: marker/mechanism
protein:increased expression, activity:serum:
CTD
RGD
PMID:145039 PMID:19481104 PMID:19085960 PMID:19085960 PMID:27293452 More... RGD:14975249, RGD:14975249, RGD:14975168, RGD:14975166, RGD:14975162 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
JBrowse link
G GPT2 glutamic--pyruvic transaminase 2 ISO protein:increased expression, activity:serum: RGD PMID:19085960 PMID:19085960 RGD:14975249, RGD:14975249 NCBI chr16:46,884,362...46,931,289
Ensembl chr16:46,884,362...46,931,289
JBrowse link
G GRK4 G protein-coupled receptor kinase 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:2,963,571...3,040,760
Ensembl chr 4:2,963,571...3,040,760
JBrowse link
G GSN gelsolin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 9:121,201,483...121,332,842
Ensembl chr 9:121,207,794...121,332,843
JBrowse link
G GSR glutathione-disulfide reductase treatment ISO
EXP
mRNA, protein:increased expression:liver
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:25226513 PMID:28069987 PMID:23554813 PMID:24154663 RGD:7257532, RGD:10401878 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
JBrowse link
G GSTA1 glutathione S-transferase alpha 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28412881 NCBI chr 6:52,791,371...52,803,816
Ensembl chr 6:52,791,371...52,803,860
JBrowse link
G GSTA4 glutathione S-transferase alpha 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:52,977,953...52,995,284
Ensembl chr 6:52,977,948...52,995,304
JBrowse link
G GSTM1 glutathione S-transferase mu 1 no_association EXP
IAGP
ISO
CTD Direct Evidence: marker/mechanism
protein:increased expression:liver
CTD
RGD
PMID:17465707 PMID:18666253 PMID:25501156 PMID:24465778 PMID:24903797 More... RGD:14700970, RGD:14700959, RGD:14700941, RGD:14700937, RGD:7241599 NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
JBrowse link
G GSTM2 glutathione S-transferase mu 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
JBrowse link
G GSTM3 glutathione S-transferase mu 3 EXP CTD Direct Evidence: therapeutic CTD PMID:25743375 NCBI chr 1:109,733,937...109,741,038
Ensembl chr 1:109,733,932...109,741,038
JBrowse link
G GSTM4 glutathione S-transferase mu 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:109,656,099...109,667,727
Ensembl chr 1:109,656,099...109,665,496
JBrowse link
G GSTO1 glutathione S-transferase omega 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:104,254,173...104,267,455
Ensembl chr10:104,235,356...104,267,459
JBrowse link
G GSTP1 glutathione S-transferase pi 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:25226513 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G GSTT1 glutathione S-transferase theta 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18397238 PMID:18666253 PMID:25226513
G GULOP gulonolactone (L-) oxidase, pseudogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 8:27,577,611...27,589,073
Ensembl chr 8:27,560,274...27,589,073
JBrowse link
G H19 H19 imprinted maternally expressed transcript EXP CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr11:1,995,176...2,001,466
Ensembl chr11:1,995,166...2,004,552
JBrowse link
G H2AX H2A.X variant histone treatment ISO RGD PMID:23265463 RGD:8693741 NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
JBrowse link
G HACL1 2-hydroxyacyl-CoA lyase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 3:15,560,699...15,601,569
Ensembl chr 3:15,560,699...15,601,852
JBrowse link
G HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,244,672
JBrowse link
G HAMP hepcidin antimicrobial peptide ISO mRNA:increased expression:hepatocyte RGD PMID:24373749 RGD:11041724 NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
JBrowse link
G HAO2 hydroxyacid oxidase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:119,368,785...119,394,130
Ensembl chr 1:119,368,779...119,394,130
JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
JBrowse link
G HBA1 hemoglobin subunit alpha 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:176,680...177,522
Ensembl chr16:176,680...177,522
JBrowse link
G HCP5 HLA complex P5 IAGP ClinVar Annotator: match by term: Drug-induced liver injury due to flucloxacillin ClinVar PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 More... NCBI chr 6:31,463,180...31,465,809
Ensembl chr 6:31,463,170...31,478,936
JBrowse link
G HLA-A major histocompatibility complex, class I, A EXP CTD Direct Evidence: marker/mechanism CTD PMID:21570397 PMID:28043905 NCBI chr 6:29,942,532...29,945,870
Ensembl chr 6:29,941,260...29,949,572
JBrowse link
G HLA-B major histocompatibility complex, class I, B IAGP
EXP
ClinVar Annotator: match by term: Drug-induced liver injury due to flucloxacillin
CTD Direct Evidence: marker/mechanism
ClinVar
CTD
PMID:11888582 PMID:11943262 PMID:12462283 PMID:15024131 PMID:15247624 More... NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
JBrowse link
G HLA-DQA1 major histocompatibility complex, class II, DQ alpha 1 susceptibility IAGP DNA:polymorphism: :HLA-DQA1*0102(human)
associated with tuberculosis;DNA:polymorphism: :HLA-DQA1*0102(human)
RGD PMID:20639878 PMID:12359646 RGD:14398844, RGD:14401573 NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
JBrowse link
G HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 susceptibility EXP
IAGP
CTD Direct Evidence: marker/mechanism
DNA:polymorphism: :HLA-DQB1*05(human)
DNA:polymorphism, haplotype
CTD
RGD
PMID:21570397 PMID:25250564 PMID:26959717 RGD:36174016, RGD:11573514 NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
JBrowse link
G HLA-DRB1 major histocompatibility complex, class II, DR beta 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21570397 NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
JBrowse link
G HMGB1 high mobility group box 1 treatment EXP
ISO
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:19783637 PMID:29091898 RGD:15090820 NCBI chr13:30,456,704...30,617,597
Ensembl chr13:30,456,704...30,617,597
JBrowse link
G HMOX1 heme oxygenase 1 treatment ISO
EXP
CTD Direct Evidence: marker/mechanism|therapeutic CTD
RGD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898 RGD:10762620, RGD:15090820 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HPD 4-hydroxyphenylpyruvate dioxygenase EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:22872058 NCBI chr12:121,839,527...121,888,611
Ensembl chr12:121,839,527...121,863,596
JBrowse link
G HPRT1 hypoxanthine phosphoribosyltransferase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:134,460,165...134,500,668
Ensembl chr  X:134,460,165...134,520,513
JBrowse link
G HPX hemopexin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617
JBrowse link
G HRH2 histamine receptor H2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22926047 NCBI chr 5:175,658,071...175,710,756
Ensembl chr 5:175,658,030...175,710,756
JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 ISO protein:altered localization:liver (rat) RGD PMID:12376827 RGD:10059389 NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
JBrowse link
G ICAM1 intercellular adhesion molecule 1 treatment ISO RGD PMID:29091898 RGD:15090820 NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
JBrowse link
G IDH2 isocitrate dehydrogenase (NADP(+)) 2 severity ISO RGD PMID:31121248 RGD:14985250 NCBI chr15:90,083,045...90,102,468
Ensembl chr15:90,083,045...90,102,477
JBrowse link
G IDO2 indoleamine 2,3-dioxygenase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32289347 NCBI chr 8:39,934,651...40,016,392
Ensembl chr 8:39,934,614...40,016,392
JBrowse link
G IFNA2 interferon alpha 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:1670585 NCBI chr 9:21,384,255...21,385,398
Ensembl chr 9:21,384,255...21,385,398
JBrowse link
G IFNG interferon gamma EXP
ISO
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12153990 PMID:21245496 PMID:30013034 RGD:14975100 NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
JBrowse link
G IGF1 insulin like growth factor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:23639586 PMID:25226513 NCBI chr12:102,395,874...102,481,839
Ensembl chr12:102,395,874...102,481,744
JBrowse link
G IL11 interleukin 11 EXP CTD Direct Evidence: therapeutic CTD PMID:11421492 NCBI chr19:55,364,382...55,370,463
Ensembl chr19:55,364,382...55,370,463
JBrowse link
G IL12B interleukin 12B EXP CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr 5:159,314,780...159,330,487
Ensembl chr 5:159,314,780...159,330,863
JBrowse link
G IL17A interleukin 17A EXP CTD Direct Evidence: marker/mechanism CTD PMID:19633216 PMID:24949944 NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
JBrowse link
G IL18 interleukin 18 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19164858 NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,253...112,164,096
JBrowse link
G IL1A interleukin 1 alpha EXP CTD Direct Evidence: therapeutic CTD PMID:8218930 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
JBrowse link
G IL1B interleukin 1 beta treatment ISO
EXP
CTD Direct Evidence: marker/mechanism|therapeutic CTD
RGD
PMID:19164858 PMID:28138970 PMID:23102243 PMID:29091898 PMID:31342809 More... RGD:7204421, RGD:15090820, RGD:15036799, RGD:14975281, RGD:13793380 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL1R2 interleukin 1 receptor type 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 2:101,991,960...102,028,544
Ensembl chr 2:101,991,960...102,028,544
JBrowse link
G IL22 interleukin 22 EXP CTD Direct Evidence: therapeutic CTD PMID:15122762 PMID:16212920 PMID:23375450 NCBI chr12:68,248,242...68,253,604
Ensembl chr12:68,248,242...68,253,604
JBrowse link
G IL4 interleukin 4 EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21094227 PMID:21735453 PMID:22107450 NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
JBrowse link
G IL6 interleukin 6 treatment EXP
ISO
CTD Direct Evidence: therapeutic CTD
RGD
PMID:7532385 PMID:15763341 PMID:29091898 RGD:15090820 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G IMMT inner membrane mitochondrial protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 2:86,143,936...86,195,462
Ensembl chr 2:86,143,932...86,195,472
JBrowse link
G IRAK1 interleukin 1 receptor associated kinase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:154,010,507...154,019,902
Ensembl chr  X:154,010,506...154,019,902
JBrowse link
G ITPR1 inositol 1,4,5-trisphosphate receptor type 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:4,493,348...4,847,506
Ensembl chr 3:4,493,345...4,847,506
JBrowse link
G JUND JunD proto-oncogene, AP-1 transcription factor subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr19:18,279,694...18,281,622
Ensembl chr19:18,279,694...18,281,622
JBrowse link
G KEAP1 kelch like ECH associated protein 1 ISO RGD PMID:18417483 RGD:6893370 NCBI chr19:10,486,125...10,503,356
Ensembl chr19:10,486,125...10,503,558
JBrowse link
G KITLG KIT ligand ISO CTD Direct Evidence: therapeutic CTD PMID:12594235 NCBI chr12:88,492,793...88,580,471
Ensembl chr12:88,492,793...88,580,851
JBrowse link
G KNG1 kininogen 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:30685357 NCBI chr 3:186,717,359...186,744,410
Ensembl chr 3:186,717,348...186,744,410
JBrowse link
G KRT18 keratin 18 ISO
EXP
mRNA, protein:increased expression:liver (mouse)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:19783637 PMID:33483742 PMID:17340120 RGD:18337498 NCBI chr12:52,948,855...52,952,906
Ensembl chr12:52,948,871...52,952,906
JBrowse link
G KRT8 keratin 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:52,897,191...52,949,860
Ensembl chr12:52,897,187...52,949,954
JBrowse link
G LAP3 leucine aminopeptidase 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:17,577,198...17,607,970
Ensembl chr 4:17,577,198...17,607,972
JBrowse link
G LBP lipopolysaccharide binding protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr20:38,346,482...38,377,013
Ensembl chr20:38,346,482...38,377,013
JBrowse link
G LCAT lecithin-cholesterol acyltransferase ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr16:67,939,750...67,944,120
Ensembl chr16:67,939,750...67,944,131
JBrowse link
G LCN2 lipocalin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:20623750 NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
JBrowse link
G LDLR low density lipoprotein receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:36108984 NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
JBrowse link
G LGALS3 galectin 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22461450 NCBI chr14:55,129,252...55,145,430
Ensembl chr14:55,124,110...55,145,423
JBrowse link
G LIPC lipase C, hepatic type ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr15:58,431,991...58,569,844
Ensembl chr15:58,410,569...58,569,844
JBrowse link
G LPL lipoprotein lipase treatment ISO RGD PMID:27071702 RGD:13794380 NCBI chr 8:19,939,253...19,967,259
Ensembl chr 8:19,901,717...19,967,259
JBrowse link
G LRAT lecithin retinol acyltransferase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:154,740,838...154,753,120
Ensembl chr 4:154,626,945...154,753,120
JBrowse link
G LTB4R leukotriene B4 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28487374 NCBI chr14:24,311,502...24,318,036
Ensembl chr14:24,311,450...24,318,036
JBrowse link
G LTF lactotransferrin EXP CTD Direct Evidence: therapeutic CTD PMID:16141546 NCBI chr 3:46,435,645...46,485,234
Ensembl chr 3:46,435,645...46,485,234
JBrowse link
G MALAT1 metastasis associated lung adenocarcinoma transcript 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,640...65,508,073
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
JBrowse link
G MAP3K5 mitogen-activated protein kinase kinase kinase 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:18700144 NCBI chr 6:136,557,046...136,793,091
Ensembl chr 6:136,557,046...136,793,097
JBrowse link
G MAT1A methionine adenosyltransferase 1A EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:80,271,820...80,289,658
Ensembl chr10:80,271,820...80,289,658
JBrowse link
G MCCC1 methylcrotonyl-CoA carboxylase subunit 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:183,015,218...183,116,196
Ensembl chr 3:183,015,218...183,116,075
JBrowse link
G MDH1 malate dehydrogenase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 2:63,588,963...63,607,197
Ensembl chr 2:63,588,609...63,607,197
JBrowse link
G ME1 malic enzyme 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051
JBrowse link
G MED1 mediator complex subunit 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16109766 NCBI chr17:39,404,285...39,451,263
Ensembl chr17:39,404,285...39,451,272
JBrowse link
G MIR1-1 microRNA 1-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30125006 NCBI chr20:62,554,306...62,554,376
Ensembl chr20:62,554,306...62,554,376
JBrowse link
G MIR100 microRNA 100 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:122,152,229...122,152,308
Ensembl chr11:122,152,229...122,152,308
JBrowse link
G MIR103A1 microRNA 103a-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 5:168,560,896...168,560,973
Ensembl chr 5:168,560,896...168,560,973
JBrowse link
G MIR106B microRNA 106b IEP
IDA
miRNA:decreased expression:liver (rat)
DNA:hypermethylation:promoter
RGD PMID:29554950 PMID:29554950 RGD:15042854, RGD:15042854 NCBI chr 7:100,093,993...100,094,074
Ensembl chr 7:100,093,993...100,094,074
JBrowse link
G MIR107 microRNA 107 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr10:89,592,747...89,592,827
Ensembl chr10:89,592,747...89,592,827
JBrowse link
G MIR10A microRNA 10a EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr17:48,579,838...48,579,947
Ensembl chr17:48,579,838...48,579,947
JBrowse link
G MIR10B microRNA 10b EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 2:176,150,303...176,150,412
Ensembl chr 2:176,150,303...176,150,412
JBrowse link
G MIR122 microRNA 122 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22045675 PMID:22363424 PMID:25359176 PMID:25527335 PMID:26489516 More... NCBI chr18:58,451,074...58,451,158
Ensembl chr18:58,451,074...58,451,158
JBrowse link
G MIR1246 microRNA 1246 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 2:176,600,980...176,601,052
Ensembl chr 2:176,600,980...176,601,052
JBrowse link
G MIR1247 microRNA 1247 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:101,560,287...101,560,422
Ensembl chr14:101,560,287...101,560,422
JBrowse link
G MIR1249 microRNA 1249 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr22:45,200,954...45,201,019
Ensembl chr22:45,200,954...45,201,019
JBrowse link
G MIR125B1 microRNA 125b-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:122,099,757...122,099,844
Ensembl chr11:122,099,757...122,099,844
JBrowse link
G MIR125B2 microRNA 125b-2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr21:16,590,237...16,590,325
Ensembl chr21:16,590,237...16,590,325
JBrowse link
G MIR1260A microRNA 1260a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:77,266,218...77,266,290
Ensembl chr14:77,266,218...77,266,290
JBrowse link
G MIR1260B microRNA 1260b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:96,341,438...96,341,526
Ensembl chr11:96,341,438...96,341,526
JBrowse link
G MIR1273H microRNA 1273h EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:24,203,116...24,203,231
Ensembl chr16:24,203,116...24,203,231
JBrowse link
G MIR1285-1 microRNA 1285-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:92,204,015...92,204,098
Ensembl chr 7:92,204,015...92,204,098
JBrowse link
G MIR1290 microRNA 1290 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 1:18,897,071...18,897,148
Ensembl chr 1:18,897,071...18,897,148
JBrowse link
G MIR1291 microRNA 1291 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:48,654,444...48,654,530
Ensembl chr12:48,654,444...48,654,530
JBrowse link
G MIR1303 microRNA 1303 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 5:154,685,776...154,685,861
Ensembl chr 5:154,685,776...154,685,861
JBrowse link
G MIR1304 microRNA 1304 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:93,733,674...93,733,764
Ensembl chr11:93,733,674...93,733,764
JBrowse link
G MIR1306 microRNA 1306 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr22:20,086,058...20,086,142
Ensembl chr22:20,086,058...20,086,142
JBrowse link
G MIR1307 microRNA 1307 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr10:103,394,253...103,394,401
Ensembl chr10:103,394,253...103,394,401
JBrowse link
G MIR130A microRNA 130a EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr11:57,641,198...57,641,286
Ensembl chr11:57,641,198...57,641,286
JBrowse link
G MIR130B microRNA 130b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr22:21,653,304...21,653,385
Ensembl chr22:21,653,304...21,653,385
JBrowse link
G MIR132 microRNA 132 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr17:2,049,908...2,050,008
Ensembl chr17:2,049,908...2,050,008
JBrowse link
G MIR1343 microRNA 1343 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:34,941,837...34,941,920
Ensembl chr11:34,941,837...34,941,920
JBrowse link
G MIR141 microRNA 141 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr12:6,964,097...6,964,191
Ensembl chr12:6,964,097...6,964,191
JBrowse link
G MIR142 microRNA 142 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:58,331,232...58,331,318
Ensembl chr17:58,331,232...58,331,318
JBrowse link
G MIR143 microRNA 143 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30125006 NCBI chr 5:149,428,918...149,429,023
Ensembl chr 5:149,428,918...149,429,023
JBrowse link
G MIR1468 microRNA 1468 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:63,786,002...63,786,087
Ensembl chr  X:63,786,002...63,786,087
JBrowse link
G MIR148A microRNA 148a EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr 7:25,949,919...25,949,986
Ensembl chr 7:25,949,919...25,949,986
JBrowse link
G MIR149 microRNA 149 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 2:240,456,001...240,456,089
Ensembl chr 2:240,456,001...240,456,089
JBrowse link
G MIR150 microRNA 150 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr19:49,500,785...49,500,868
Ensembl chr19:49,500,785...49,500,868
JBrowse link
G MIR151B microRNA 151b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:100,109,419...100,109,514
Ensembl chr14:100,109,419...100,109,514
JBrowse link
G MIR152 microRNA 152 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:48,037,161...48,037,247
Ensembl chr17:48,037,161...48,037,247
JBrowse link
G MIR155 microRNA 155 treatment ISO RGD PMID:29420849 PMID:26867493 PMID:27673475 RGD:21409750, RGD:25671474, RGD:25671463 NCBI chr21:25,573,980...25,574,044
Ensembl chr21:25,573,980...25,574,044
JBrowse link
G MIR17 microRNA 17 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:91,350,605...91,350,688
Ensembl chr13:91,350,605...91,350,688
JBrowse link
G MIR181C microRNA 181c EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr19:13,874,699...13,874,808
Ensembl chr19:13,874,699...13,874,808
JBrowse link
G MIR188 microRNA 188 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:50,003,503...50,003,588
Ensembl chr  X:50,003,503...50,003,588
JBrowse link
G MIR18A microRNA 18a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr13:91,350,751...91,350,821
Ensembl chr13:91,350,751...91,350,821
JBrowse link
G MIR191 microRNA 191 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:49,020,618...49,020,709
Ensembl chr 3:49,020,618...49,020,709
JBrowse link
G MIR192 microRNA 192 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22045675 PMID:25359176 PMID:28483554 PMID:28545106 NCBI chr11:64,891,137...64,891,246
Ensembl chr11:64,891,137...64,891,246
JBrowse link
G MIR193A microRNA 193a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:31,559,996...31,560,083
Ensembl chr17:31,559,996...31,560,083
JBrowse link
G MIR193B microRNA 193b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:14,303,967...14,304,049
Ensembl chr16:14,303,967...14,304,049
JBrowse link
G MIR194-1 microRNA 194-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28844483 NCBI chr 1:220,118,157...220,118,241
Ensembl chr 1:220,118,157...220,118,241
JBrowse link
G MIR19A microRNA 19a EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr13:91,350,891...91,350,972
Ensembl chr13:91,350,891...91,350,972
JBrowse link
G MIR200C microRNA 200c EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr12:6,963,699...6,963,766
Ensembl chr12:6,963,699...6,963,766
JBrowse link
G MIR203B microRNA 203b ISO CTD Direct Evidence: therapeutic CTD PMID:32659284 NCBI chr14:104,117,418...104,117,503
Ensembl chr14:104,117,418...104,117,503
JBrowse link
G MIR21 microRNA 21 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:59,841,266...59,841,337
Ensembl chr17:59,841,266...59,841,337
JBrowse link
G MIR210 microRNA 210 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:568,089...568,198
Ensembl chr11:568,089...568,198
JBrowse link
G MIR217 microRNA 217 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 2:55,982,967...55,983,076
Ensembl chr 2:55,982,967...55,983,076
JBrowse link
G MIR218-1 microRNA 218-1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:30125006 NCBI chr 4:20,528,275...20,528,384
Ensembl chr 4:20,528,275...20,528,384
JBrowse link
G MIR22 microRNA 22 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr17:1,713,903...1,713,987
Ensembl chr17:1,713,903...1,713,987
JBrowse link
G MIR221 microRNA 221 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:45,746,157...45,746,266
Ensembl chr  X:45,746,157...45,746,266
JBrowse link
G MIR222 microRNA 222 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:45,747,015...45,747,124
Ensembl chr  X:45,747,015...45,747,124
JBrowse link
G MIR223 microRNA 223 ISO RNA:increased expression:serum,liver RGD PMID:28646120 RGD:21408574 NCBI chr  X:66,018,870...66,018,979
Ensembl chr  X:66,018,870...66,018,979
JBrowse link
G MIR23A microRNA 23a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr19:13,836,587...13,836,659
Ensembl chr19:13,836,587...13,836,659
JBrowse link
G MIR23B microRNA 23b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:95,085,208...95,085,304
Ensembl chr 9:95,085,208...95,085,304
JBrowse link
G MIR27B microRNA 27b EXP CTD Direct Evidence: marker/mechanism CTD PMID:25359176 PMID:28545106 NCBI chr 9:95,085,445...95,085,541
Ensembl chr 9:95,085,445...95,085,541
JBrowse link
G MIR29B2 microRNA 29b-2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 1:207,802,443...207,802,523
Ensembl chr 1:207,802,443...207,802,523
JBrowse link
G MIR29C microRNA 29c EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30515189 NCBI chr 1:207,801,852...207,801,939
Ensembl chr 1:207,801,852...207,801,939
JBrowse link
G MIR301A microRNA 301a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:59,151,136...59,151,221
Ensembl chr17:59,151,136...59,151,221
JBrowse link
G MIR30A microRNA 30a EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:25359176 PMID:28545106 NCBI chr 6:71,403,551...71,403,621
Ensembl chr 6:71,403,551...71,403,621
JBrowse link
G MIR30B microRNA 30b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 8:134,800,520...134,800,607
Ensembl chr 8:134,800,520...134,800,607
JBrowse link
G MIR30C1 microRNA 30c-1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 1:40,757,284...40,757,372
Ensembl chr 1:40,757,284...40,757,372
JBrowse link
G MIR320A microRNA 320a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30125006 NCBI chr 8:22,244,966...22,245,037
Ensembl chr 8:22,244,962...22,245,043
JBrowse link
G MIR328 microRNA 328 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:67,202,321...67,202,395
Ensembl chr16:67,202,321...67,202,395
JBrowse link
G MIR335 microRNA 335 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:130,496,111...130,496,204
Ensembl chr 7:130,496,111...130,496,204
JBrowse link
G MIR337 microRNA 337 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr14:100,874,493...100,874,585
Ensembl chr14:100,874,493...100,874,585
JBrowse link
G MIR338 microRNA 338 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:81,125,883...81,125,949
Ensembl chr17:81,125,883...81,125,949
JBrowse link
G MIR33B microRNA 33b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:17,813,836...17,813,931
Ensembl chr17:17,813,836...17,813,931
JBrowse link
G MIR342 microRNA 342 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:100,109,655...100,109,753
Ensembl chr14:100,109,655...100,109,753
JBrowse link
G MIR345 microRNA 345 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:100,307,859...100,307,956
Ensembl chr14:100,307,859...100,307,956
JBrowse link
G MIR34A microRNA 34a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 1:9,151,668...9,151,777
Ensembl chr 1:9,151,668...9,151,777
JBrowse link
G MIR34C microRNA 34c EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr11:111,513,439...111,513,515
Ensembl chr11:111,513,439...111,513,515
JBrowse link
G MIR3591 microRNA 3591 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr18:58,451,080...58,451,152
Ensembl chr18:58,451,080...58,451,152
JBrowse link
G MIR361 microRNA 361 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:85,903,636...85,903,707
Ensembl chr  X:85,903,636...85,903,707
JBrowse link
G MIR3615 microRNA 3615 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:74,748,613...74,748,699
Ensembl chr17:74,748,613...74,748,699
JBrowse link
G MIR362 microRNA 362 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:50,008,964...50,009,028
Ensembl chr  X:50,008,964...50,009,028
JBrowse link
G MIR367 microRNA 367 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr 4:112,647,874...112,647,941
Ensembl chr 4:112,647,874...112,647,941
JBrowse link
G MIR378A microRNA 378a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 5:149,732,825...149,732,890
Ensembl chr 5:149,732,825...149,732,890
JBrowse link
G MIR378C microRNA 378c EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr10:130,962,588...130,962,668
Ensembl chr10:130,962,588...130,962,668
JBrowse link
G MIR378I microRNA 378i EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr22:41,923,222...41,923,297
Ensembl chr22:41,923,222...41,923,297
JBrowse link
G MIR410 microRNA 410 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr14:101,065,912...101,065,991
Ensembl chr14:101,065,912...101,065,991
JBrowse link
G MIR421 microRNA 421 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:74,218,377...74,218,461
Ensembl chr  X:74,218,377...74,218,461
JBrowse link
G MIR423 microRNA 423 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:30,117,079...30,117,172
Ensembl chr17:30,117,079...30,117,172
JBrowse link
G MIR4433B microRNA 4433b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 2:64,340,747...64,340,848
Ensembl chr 2:64,340,747...64,340,848
JBrowse link
G MIR4448 microRNA 4448 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:183,886,800...183,886,885
Ensembl chr 3:183,886,800...183,886,885
JBrowse link
G MIR4492 microRNA 4492 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:118,910,708...118,910,787
Ensembl chr11:118,910,708...118,910,787
JBrowse link
G MIR4507 microRNA 4507 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:105,858,124...105,858,175
Ensembl chr14:105,858,124...105,858,175
JBrowse link
G MIR4516 microRNA 4516 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:2,133,119...2,133,204
Ensembl chr16:2,133,119...2,133,204
JBrowse link
G MIR452 microRNA 452 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:151,959,628...151,959,712
Ensembl chr  X:151,959,628...151,959,712
JBrowse link
G MIR455 microRNA 455 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:114,209,434...114,209,529
Ensembl chr 9:114,209,434...114,209,529
JBrowse link
G MIR483 microRNA 483 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr11:2,134,134...2,134,209
Ensembl chr11:2,134,134...2,134,209
JBrowse link
G MIR484 microRNA 484 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr16:15,643,294...15,643,372
Ensembl chr16:15,643,294...15,643,372
JBrowse link
G MIR497 microRNA 497 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr17:7,017,911...7,018,022
Ensembl chr17:7,017,911...7,018,022
JBrowse link
G MIR499A microRNA 499a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr20:34,990,376...34,990,497
Ensembl chr20:34,990,376...34,990,497
JBrowse link
G MIR503 microRNA 503 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr  X:134,546,328...134,546,398
Ensembl chr  X:134,546,328...134,546,398
JBrowse link
G MIR505 microRNA 505 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:139,924,148...139,924,231
Ensembl chr  X:139,924,148...139,924,231
JBrowse link
G MIR5196 microRNA 5196 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr19:35,345,513...35,345,627
Ensembl chr19:35,345,513...35,345,627
JBrowse link
G MIR532 microRNA 532 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:50,003,148...50,003,238
Ensembl chr  X:50,003,148...50,003,238
JBrowse link
G MIR5588 microRNA 5588 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:185,253,210...185,253,272
Ensembl chr 3:185,253,210...185,253,272
JBrowse link
G MIR574 microRNA 574 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 4:38,868,032...38,868,127
Ensembl chr 4:38,868,032...38,868,127
JBrowse link
G MIR589 microRNA 589 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:5,495,819...5,495,917
Ensembl chr 7:5,495,819...5,495,917
JBrowse link
G MIR592 microRNA 592 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr 7:127,058,088...127,058,184
Ensembl chr 7:127,058,088...127,058,184
JBrowse link
G MIR625 microRNA 625 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr14:65,471,102...65,471,186
Ensembl chr14:65,471,102...65,471,186
JBrowse link
G MIR627 microRNA 627 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr15:42,199,570...42,199,666
Ensembl chr15:42,199,570...42,199,666
JBrowse link
G MIR629 microRNA 629 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr15:70,079,372...70,079,468
Ensembl chr15:70,079,372...70,079,468
JBrowse link
G MIR651 microRNA 651 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:8,126,965...8,127,061
Ensembl chr  X:8,126,965...8,127,061
JBrowse link
G MIR660 microRNA 660 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:50,013,241...50,013,337
Ensembl chr  X:50,013,241...50,013,337
JBrowse link
G MIR6741 microRNA 6741 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 1:225,922,080...225,922,142
Ensembl chr 1:225,922,080...225,922,142
JBrowse link
G MIR6815 microRNA 6815 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr21:45,478,266...45,478,326
Ensembl chr21:45,478,266...45,478,326
JBrowse link
G MIR6852 microRNA 6852 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:35,710,676...35,710,741
Ensembl chr 9:35,710,676...35,710,741
JBrowse link
G MIR744 microRNA 744 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 PMID:28545106 NCBI chr17:12,081,899...12,081,996
Ensembl chr17:12,081,899...12,081,996
JBrowse link
G MIR764 microRNA 764 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22363424 NCBI chr  X:114,639,435...114,639,519
Ensembl chr  X:114,639,435...114,639,519
JBrowse link
G MIR766 microRNA 766 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr  X:119,646,738...119,646,848
Ensembl chr  X:119,646,738...119,646,848
JBrowse link
G MIR7704 microRNA 7704 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 2:176,188,843...176,188,901
Ensembl chr 2:176,188,843...176,188,901
JBrowse link
G MIR7977 microRNA 7977 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:176,515,103...176,515,151
Ensembl chr 3:176,515,103...176,515,151
JBrowse link
G MIR877 microRNA 877 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27713024 NCBI chr 6:30,584,332...30,584,417
Ensembl chr 6:30,584,332...30,584,417
JBrowse link
G MIR885 microRNA 885 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:10,394,489...10,394,562
Ensembl chr 3:10,394,489...10,394,562
JBrowse link
G MIR93 microRNA 93 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 7:100,093,768...100,093,847
Ensembl chr 7:100,093,768...100,093,847
JBrowse link
G MIR99A microRNA 99a EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr21:16,539,089...16,539,169
Ensembl chr21:16,539,089...16,539,169
JBrowse link
G MIRLET7B microRNA let-7b EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 PMID:30125006 NCBI chr22:46,113,686...46,113,768
Ensembl chr22:46,113,686...46,113,768
JBrowse link
G MIRLET7C microRNA let-7c EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr21:16,539,828...16,539,911
Ensembl chr21:16,539,828...16,539,911
JBrowse link
G MIRLET7D microRNA let-7d EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 9:94,178,834...94,178,920
Ensembl chr 9:94,178,834...94,178,920
JBrowse link
G MIRLET7G microRNA let-7g EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr 3:52,268,278...52,268,361
Ensembl chr 3:52,268,278...52,268,361
JBrowse link
G MIRLET7I microRNA let-7i EXP CTD Direct Evidence: marker/mechanism CTD PMID:28545106 NCBI chr12:62,603,686...62,603,769
Ensembl chr12:62,603,686...62,603,769
JBrowse link
G MMP2 matrix metallopeptidase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15763341 NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
JBrowse link
G MMP9 matrix metallopeptidase 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
JBrowse link
G MST1 macrophage stimulating 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:49,683,947...49,689,474
Ensembl chr 3:49,683,947...49,689,501
JBrowse link
G MST1R macrophage stimulating 1 receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:22575169 NCBI chr 3:49,887,002...49,903,873
Ensembl chr 3:49,887,002...49,903,873
JBrowse link
G MT-ND6 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 ISO mRNA:decreased expression:blood RGD PMID:20130021 RGD:8657129 NCBI chr MT:14,149...14,673
Ensembl chr MT:14,149...14,673
JBrowse link
G MTHFR methylenetetrahydrofolate reductase treatment EXP
IAGP
CTD Direct Evidence: marker/mechanism
associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human)
CTD
RGD
PMID:18551038 PMID:19648163 PMID:30545275 RGD:14696733 NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
JBrowse link
G MTPN myotrophin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:135,926,760...135,977,359
Ensembl chr 7:135,926,760...135,977,359
JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor ameliorates ISO RGD PMID:17615358 RGD:150521532 NCBI chr 3:38,138,661...38,143,022
Ensembl chr 3:38,138,552...38,143,024
JBrowse link
G NAT2 N-acetyltransferase 2 treatment IAGP
EXP
associated with Tuberculosis;DNA:haplotype: :
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:11915035 PMID:16799928 PMID:17950035 PMID:25693865 PMID:18023090 RGD:8552665 NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
JBrowse link
G NDUFS3 NADH:ubiquinone oxidoreductase core subunit S3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:47,579,074...47,584,562
Ensembl chr11:47,565,336...47,584,562
JBrowse link
G NFATC4 nuclear factor of activated T cells 4 EXP CTD Direct Evidence: therapeutic CTD PMID:34192554 NCBI chr14:24,366,911...24,379,604
Ensembl chr14:24,365,673...24,379,604
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 treatment ISO
EXP
induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620)
CTD Direct Evidence: therapeutic
CTD
RGD
PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 PMID:30215777 More... RGD:6893370, RGD:21201308, RGD:21201305, RGD:21201283, RGD:21201280, RGD:15090820 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 treatment
susceptibility
ISO
IAGP
associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human) RGD PMID:29091898 PMID:31490979 RGD:15090820, RGD:40902984 NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
JBrowse link
G NFXL1 nuclear transcription factor, X-box binding like 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 4:47,847,233...47,914,667
Ensembl chr 4:47,847,233...47,914,667
JBrowse link
G NME2 NME/NM23 nucleoside diphosphate kinase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr17:51,165,536...51,171,744
Ensembl chr17:51,165,435...51,171,744
JBrowse link
G NOTCH1 notch receptor 1 EXP CTD Direct Evidence: therapeutic CTD PMID:30394310 NCBI chr 9:136,494,433...136,546,048
Ensembl chr 9:136,494,433...136,546,048
JBrowse link
G NOX4 NADPH oxidase 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:89,324,353...89,589,557
Ensembl chr11:89,324,353...89,498,187
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 treatment ISO RGD PMID:28522909 PMID:29091898 PMID:28472605 RGD:13439737, RGD:15090820, RGD:13439739 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 EXP CTD Direct Evidence: therapeutic CTD PMID:29943110 NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
JBrowse link
G NR1D1 nuclear receptor subfamily 1 group D member 1 treatment ISO RGD PMID:24497272 RGD:10448995 NCBI chr17:40,092,793...40,100,589
Ensembl chr17:40,092,793...40,100,589
JBrowse link
G NR1H3 nuclear receptor subfamily 1 group H member 3 EXP CTD Direct Evidence: therapeutic CTD PMID:17256725 NCBI chr11:47,248,300...47,269,033
Ensembl chr11:47,248,300...47,269,033
JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 treatment
severity
EXP
ISO
CTD Direct Evidence: marker/mechanism
mRNA:decreased expression:liver (rat)
protein:decreased expression:liver (rat)
CTD
RGD
PMID:12875239 PMID:29091898 PMID:28827769 PMID:30068870 PMID:22711662 More... RGD:15090820, RGD:15045609, RGD:15042870, RGD:14701036, RGD:14701035 NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 susceptibility EXP
IAGP
CTD Direct Evidence: marker/mechanism|therapeutic
associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human)
CTD
RGD
PMID:19797606 PMID:28058446 PMID:31490979 RGD:40902984 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:14742670 PMID:25656644 PMID:28058446 NCBI chr 1:161,229,669...161,238,203
Ensembl chr 1:161,229,666...161,238,244
JBrowse link
G NR2F2 nuclear receptor subfamily 2 group F member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:96,326,046...96,340,263
Ensembl chr15:96,325,938...96,340,263
JBrowse link
G NR5A2 nuclear receptor subfamily 5 group A member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29515023 NCBI chr 1:200,027,710...200,177,415
Ensembl chr 1:200,027,614...200,177,420
JBrowse link
G NREP neuronal regeneration related protein EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464
JBrowse link
G NTN1 netrin 1 EXP CTD Direct Evidence: therapeutic CTD PMID:35292334 NCBI chr17:9,003,087...9,244,000
Ensembl chr17:9,021,510...9,244,000
JBrowse link
G NUS1 NUS1 dehydrodolichyl diphosphate synthase subunit EXP CTD Direct Evidence: therapeutic CTD PMID:33812996 NCBI chr 6:117,675,469...117,710,727
Ensembl chr 6:117,675,469...117,710,727
JBrowse link
G OCIAD1 OCIA domain containing 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:48,805,156...48,861,815
Ensembl chr 4:48,805,212...48,861,817
JBrowse link
G OGDH oxoglutarate dehydrogenase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:44,606,627...44,709,066
Ensembl chr 7:44,606,572...44,709,066
JBrowse link
G OR51E2 olfactory receptor family 51 subfamily E member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:4,680,171...4,697,853
Ensembl chr11:4,680,171...4,697,854
JBrowse link
G P4HB prolyl 4-hydroxylase subunit beta EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr17:81,843,166...81,860,535
Ensembl chr17:81,843,159...81,860,856
JBrowse link
G PAH phenylalanine hydroxylase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:102,836,889...102,958,441
Ensembl chr12:102,836,889...102,958,410
JBrowse link
G PAN2 poly(A) specific ribonuclease subunit PAN2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr12:56,316,936...56,334,000
Ensembl chr12:56,316,223...56,334,053
JBrowse link
G PANX1 pannexin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:29246445 NCBI chr11:94,128,841...94,181,968
Ensembl chr11:94,128,841...94,181,968
JBrowse link
G PARK7 Parkinsonism associated deglycase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:7,961,711...7,985,505
Ensembl chr 1:7,954,291...7,985,505
JBrowse link
G PC pyruvate carboxylase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
JBrowse link
G PCOLCE procollagen C-endopeptidase enhancer EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:100,602,363...100,608,175
Ensembl chr 7:100,602,363...100,608,175
JBrowse link
G PCYT1A phosphate cytidylyltransferase 1A, choline EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:196,234,368...196,287,726
Ensembl chr 3:196,214,222...196,287,957
JBrowse link
G PDK4 pyruvate dehydrogenase kinase 4 EXP CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21182459 PMID:31809757 NCBI chr 7:95,583,499...95,596,516
Ensembl chr 7:95,583,499...95,596,516
JBrowse link
G PDLIM5 PDZ and LIM domain 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:94,451,942...94,668,223
Ensembl chr 4:94,451,857...94,668,227
JBrowse link
G PEX11A peroxisomal biogenesis factor 11 alpha EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr15:89,681,535...89,690,754
Ensembl chr15:89,677,764...89,690,783
JBrowse link
G PGM1 phosphoglucomutase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:63,593,411...63,660,245
Ensembl chr 1:63,593,411...63,660,245
JBrowse link
G PLAT plasminogen activator, tissue type EXP CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr 8:42,174,718...42,207,565
Ensembl chr 8:42,174,718...42,207,709
JBrowse link
G PLG plasminogen EXP CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr 6:160,702,193...160,754,097
Ensembl chr 6:160,702,194...160,754,097
JBrowse link
G PLS3 plastin 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:115,561,174...115,650,861
Ensembl chr  X:115,561,174...115,650,861
JBrowse link
G PNP purine nucleoside phosphorylase EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr14:20,469,406...20,477,089
Ensembl chr14:20,461,992...20,477,094
JBrowse link
G PNRC1 proline rich nuclear receptor coactivator 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:89,080,751...89,085,160
Ensembl chr 6:89,080,751...89,085,160
JBrowse link
G POLG DNA polymerase gamma, catalytic subunit susceptibility
no_association
EXP
IAGP
CTD Direct Evidence: marker/mechanism
DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human)
DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human)
CTD
RGD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931 RGD:15039302, RGD:15039297 NCBI chr15:89,316,320...89,334,824
Ensembl chr15:89,305,198...89,334,861
JBrowse link
G POLR2G RNA polymerase II subunit G EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:62,761,580...62,766,710
Ensembl chr11:62,761,565...62,766,710
JBrowse link
G PON1 paraoxonase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha ISO
EXP
LPS-induced acute liver damage
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:24385052 PMID:21262334 RGD:5509941 NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,755
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma ISO mRNA, protein:decreased expression:liver RGD PMID:26599535 RGD:11554658 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
G PPTC7 protein phosphatase targeting COQ7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:110,533,245...110,583,318
Ensembl chr12:110,533,245...110,583,318
JBrowse link
G PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 treatment ISO RGD PMID:29091898 RGD:15090820 NCBI chr 5:40,759,389...40,798,374
Ensembl chr 5:40,759,389...40,798,374
JBrowse link
G PRKCD protein kinase C delta EXP CTD Direct Evidence: therapeutic CTD PMID:30393195 NCBI chr 3:53,161,209...53,192,717
Ensembl chr 3:53,156,009...53,192,717
JBrowse link
G PRKDC protein kinase, DNA-activated, catalytic subunit EXP CTD Direct Evidence: marker/mechanism CTD PMID:21224054 NCBI chr 8:47,773,111...47,960,136
Ensembl chr 8:47,773,111...47,960,178
JBrowse link
G PTF1A pancreas associated transcription factor 1a EXP CTD Direct Evidence: therapeutic CTD PMID:21182459 NCBI chr10:23,192,312...23,194,245
Ensembl chr10:23,192,312...23,194,245
JBrowse link
G PTGES2 prostaglandin E synthase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:31444509 NCBI chr 9:128,120,693...128,128,440
Ensembl chr 9:128,120,693...128,128,462
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 treatment EXP
ISO
CTD Direct Evidence: therapeutic CTD
RGD
PMID:11743745 PMID:29091898 RGD:15090820 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G PUM1 pumilio RNA binding family member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:30,931,506...31,065,717
Ensembl chr 1:30,931,506...31,065,991
JBrowse link
G PYGL glycogen phosphorylase L EXP
IEP
CTD Direct Evidence: marker/mechanism
protein:increased expression:serum (rat)
CTD
RGD
PMID:25231249 PMID:25336395 RGD:21079733 NCBI chr14:50,905,217...50,944,483
Ensembl chr14:50,857,891...50,944,483
JBrowse link
G PZP PZP alpha-2-macroglobulin like EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr12:9,136,472...9,208,395
Ensembl chr12:9,148,840...9,208,395
JBrowse link
G RASA1 RAS p21 protein activator 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:87,267,883...87,391,916
Ensembl chr 5:87,267,883...87,391,931
JBrowse link
G RBP1 retinol binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 3:139,517,438...139,539,742
Ensembl chr 3:139,517,434...139,539,829
JBrowse link
G RDH13 retinol dehydrogenase 13 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27865848 NCBI chr19:55,039,103...55,069,520
Ensembl chr19:55,039,108...55,071,291
JBrowse link
G REEP5 receptor accessory protein 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 5:112,876,385...112,922,227
Ensembl chr 5:112,876,385...112,922,289
JBrowse link
G RGN regucalcin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:47,078,443...47,093,313
Ensembl chr  X:47,078,355...47,093,314
JBrowse link
G RIPK3 receptor interacting serine/threonine kinase 3 EXP
ISO
CTD Direct Evidence: therapeutic
protein:increased expression:liver (mouse)
CTD
RGD
PMID:26769846 PMID:28205631 RGD:127229945 NCBI chr14:24,336,025...24,339,991
Ensembl chr14:24,336,025...24,340,022
JBrowse link
G S100A11 S100 calcium binding protein A11 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:152,032,506...152,037,004
Ensembl chr 1:152,032,506...152,047,907
JBrowse link
G SCARB1 scavenger receptor class B member 1 ISO mRNA:increased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr12:124,776,856...124,863,864
Ensembl chr12:124,776,856...124,882,668
JBrowse link
G SELENBP1 selenium binding protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 1:151,364,304...151,372,705
Ensembl chr 1:151,364,304...151,372,707
JBrowse link
G SEMA3A semaphorin 3A EXP CTD Direct Evidence: therapeutic CTD PMID:33290778 NCBI chr 7:83,955,777...84,492,725
Ensembl chr 7:83,955,777...84,492,724
JBrowse link
G SEMA4A semaphorin 4A EXP CTD Direct Evidence: marker/mechanism CTD PMID:33290778 NCBI chr 1:156,147,373...156,177,744
Ensembl chr 1:156,147,366...156,177,752
JBrowse link
G SENP2 SUMO specific peptidase 2 EXP CTD Direct Evidence: therapeutic CTD PMID:29535048 NCBI chr 3:185,586,295...185,633,551
Ensembl chr 3:185,582,496...185,633,551
JBrowse link
G SERPINA1 serpin family A member 1 susceptibility ISO
IAGP
protein:decreased expression:plasma
DNA:missense mutation:cds:p.E264V(human)
RGD PMID:11140575 PMID:20170533 RGD:1643168, RGD:14695048 NCBI chr14:94,376,747...94,390,635
Ensembl chr14:94,376,747...94,390,693
JBrowse link
G SERPINA6 serpin family A member 6 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:94,304,248...94,323,336
Ensembl chr14:94,304,248...94,323,389
JBrowse link
G SERPINE1 serpin family E member 1 treatment IAGP associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) RGD PMID:23183238 RGD:14696750 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
JBrowse link
G SERPING1 serpin family G member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:57,597,685...57,614,848
Ensembl chr11:57,597,387...57,619,171
JBrowse link
G SESN2 sestrin 2 EXP CTD Direct Evidence: therapeutic CTD PMID:28209544 NCBI chr 1:28,259,518...28,282,491
Ensembl chr 1:28,259,518...28,282,491
JBrowse link
G SGF29 SAGA complex associated factor 29 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:28,553,920...28,591,790
Ensembl chr16:28,553,915...28,591,790
JBrowse link
G SHC1 SHC adaptor protein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 PMID:32659284 NCBI chr 1:154,962,298...154,974,376
Ensembl chr 1:154,962,298...154,974,395
JBrowse link
G SLC10A1 solute carrier family 10 member 1 ISO mRNA:decreased expression:liver (rat) RGD PMID:28827769 RGD:15045609 NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
JBrowse link
G SLC10A7 solute carrier family 10 member 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 4:146,253,981...146,521,940
Ensembl chr 4:146,253,975...146,522,372
JBrowse link
G SLC13A4 solute carrier family 13 member 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:135,681,231...135,728,186
Ensembl chr 7:135,681,231...135,729,258
JBrowse link
G SLC22A25 solute carrier family 22 member 25 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:63,158,437...63,243,599
Ensembl chr11:63,158,437...63,243,599
JBrowse link
G SLC22A8 solute carrier family 22 member 8 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
JBrowse link
G SLC25A29 solute carrier family 25 member 29 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:100,278,567...100,306,444
Ensembl chr14:100,291,116...100,306,547
JBrowse link
G SLC7A5 solute carrier family 7 member 5 treatment ISO RGD PMID:9200186 RGD:151357001 NCBI chr16:87,830,023...87,869,507
Ensembl chr16:87,830,023...87,869,507
JBrowse link
G SLCO1B1 solute carrier organic anion transporter family member 1B1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:32259555 NCBI chr12:21,131,194...21,239,796
Ensembl chr12:21,131,194...21,239,796
JBrowse link
G SLPI secretory leukocyte peptidase inhibitor EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564
JBrowse link
G SNX18 sorting nexin 18 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 5:54,517,759...54,648,005
Ensembl chr 5:54,517,759...54,546,586
JBrowse link
G SOD1 superoxide dismutase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:27349771 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G SOD2 superoxide dismutase 2 treatment
severity
susceptibility
EXP
IAGP
ISO
CTD Direct Evidence: marker/mechanism
associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human)
DNA:SNP:cds:p.Val16Ala(human)
CTD
RGD
PMID:25226513 PMID:27019981 PMID:19647030 PMID:19332662 PMID:20578157 RGD:11060605, RGD:26923961, RGD:26923959, RGD:26923957 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
JBrowse link
G SOD3 superoxide dismutase 3 EXP CTD Direct Evidence: therapeutic CTD PMID:11529661 NCBI chr 4:24,795,573...24,800,842
Ensembl chr 4:24,789,912...24,800,842
JBrowse link
G SORD sorbitol dehydrogenase EXP CTD Direct Evidence: marker/mechanism CTD PMID:12763371 NCBI chr15:45,023,195...45,077,185
Ensembl chr15:45,023,147...45,077,185
JBrowse link
G SORL1 sortilin related receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr11:121,452,314...121,633,763
Ensembl chr11:121,452,314...121,633,763
JBrowse link
G SPIN2A spindlin family member 2A EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr  X:57,134,265...57,147,180
Ensembl chr  X:57,134,530...57,137,523
JBrowse link
G SPP1 secreted phosphoprotein 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
JBrowse link
G SRP72 signal recognition particle 72 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 4:56,467,617...56,503,681
Ensembl chr 4:56,467,617...56,503,681
JBrowse link
G STAT4 signal transducer and activator of transcription 4 severity ISO protein:increased phosphorylation:liver, inflammatory cell (mouse)
mRNA:increased expression:liver, macrophage (mouse)
RGD PMID:24731448 PMID:23876342 RGD:25671417, RGD:25671422 NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,151,596
JBrowse link
G STING1 stimulator of interferon response cGAMP interactor 1 EXP CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr 5:139,475,533...139,482,758
Ensembl chr 5:139,475,533...139,482,935
JBrowse link
G SULT1C3 sulfotransferase family 1C member 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:108,239,968...108,265,351
Ensembl chr 2:108,239,968...108,265,351
JBrowse link
G SULT1E1 sulfotransferase family 1E member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 4:69,821,122...69,860,145
Ensembl chr 4:69,841,212...69,860,145
JBrowse link
G SULT2B1 sulfotransferase family 2B member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:27052460 NCBI chr19:48,552,172...48,599,427
Ensembl chr19:48,552,172...48,599,425
JBrowse link
G SUOX sulfite oxidase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:55,997,276...56,005,525
Ensembl chr12:55,997,180...56,006,641
JBrowse link
G TAGLN2 transgelin 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:159,918,111...159,925,507
Ensembl chr 1:159,918,107...159,925,507
JBrowse link
G TALDO1 transaldolase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19436114 NCBI chr11:747,464...765,012
Ensembl chr11:747,415...765,012
JBrowse link
G TBXA2R thromboxane A2 receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:22206755 NCBI chr19:3,594,507...3,606,875
Ensembl chr19:3,594,507...3,606,875
JBrowse link
G TCTN1 tectonic family member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr12:110,614,129...110,649,430
Ensembl chr12:110,614,027...110,663,431
JBrowse link
G TF transferrin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
JBrowse link
G TGFB1 transforming growth factor beta 1 treatment ISO RGD PMID:27516150 RGD:14995464 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:28560358 NCBI chr 9:99,103,647...99,154,192
Ensembl chr 9:99,104,038...99,154,192
JBrowse link
G THBS1 thrombospondin 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:35357534 NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
JBrowse link
G THPO thrombopoietin EXP CTD Direct Evidence: therapeutic CTD PMID:33122006 NCBI chr 3:184,371,935...184,379,688
Ensembl chr 3:184,371,935...184,381,968
JBrowse link
G TLR4 toll like receptor 4 disease_progression ISO RGD PMID:17504260 RGD:14697733 NCBI chr 9:117,704,403...117,724,735
Ensembl chr 9:117,704,175...117,724,735
JBrowse link
G TLR5 toll like receptor 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:30508503 NCBI chr 1:223,109,404...223,143,248
Ensembl chr 1:223,109,404...223,143,248
JBrowse link
G TLR9 toll like receptor 9 severity
treatment
IEP
ISO
protein:increased expression: blood, neutrophil (human) RGD PMID:26457748 PMID:19164858 PMID:23509352 RGD:18337465, RGD:18337476, RGD:18337473 NCBI chr 3:52,221,080...52,225,645
Ensembl chr 3:52,221,080...52,225,645
JBrowse link
G TMED7 transmembrane p24 trafficking protein 7 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 5:115,613,210...115,626,036
Ensembl chr 5:115,613,210...115,632,992
JBrowse link
G TMEM117 transmembrane protein 117 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr12:43,795,802...44,399,108
Ensembl chr12:43,835,967...44,389,762
JBrowse link
G TMEM164 transmembrane protein 164 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:110,002,369...110,184,251
Ensembl chr  X:110,002,631...110,182,734
JBrowse link
G TMEM38B transmembrane protein 38B EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 9:105,694,541...105,776,629
Ensembl chr 9:105,694,541...105,776,629
JBrowse link
G TNF tumor necrosis factor treatment
severity
ISO
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
protein:increased expression:serum (rat)
CTD
RGD
PMID:7532385 PMID:9696492 PMID:17709330 PMID:19638433 PMID:20623750 More... RGD:10450531, RGD:15090820, RGD:15036799, RGD:14995485, RGD:14995437, RGD:14995435, RGD:14995430, RGD:14995429, RGD:14975281, RGD:14696804 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TRAJ18 T cell receptor alpha joining 18 EXP CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr14:22,525,650...22,525,715
Ensembl chr14:22,525,650...22,525,715
JBrowse link
G TRPM2 transient receptor potential cation channel subfamily M member 2 ISO RGD PMID:24569808 RGD:9999438 NCBI chr21:44,353,621...44,442,644
Ensembl chr21:44,350,163...44,443,081
JBrowse link
G TTR transthyretin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr18:31,591,877...31,598,821
Ensembl chr18:31,557,009...31,598,833
JBrowse link
G TUBA1A tubulin alpha 1a EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:49,184,795...49,189,080
Ensembl chr12:49,184,686...49,189,080
JBrowse link
G TUBB4B tubulin beta 4B class IVb EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:137,241,287...137,243,707
Ensembl chr 9:137,241,287...137,243,707
JBrowse link
G UBA5 ubiquitin like modifier activating enzyme 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 3:132,654,430...132,679,794
Ensembl chr 3:132,654,446...132,679,794
JBrowse link
G UGT1A1 UDP glucuronosyltransferase family 1 member A1 susceptibility IAGP DNA:SNP:exon (rs4148323)(human) RGD PMID:28900877 RGD:14694824 NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
JBrowse link
G UGT1A9 UDP glucuronosyltransferase family 1 member A9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 2:233,671,898...233,773,300
Ensembl chr 2:233,671,898...233,773,300
JBrowse link
G UNC93B1 unc-93 homolog B1, TLR signaling regulator EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:67,991,100...68,004,097
Ensembl chr11:67,991,100...68,004,982
JBrowse link
G USP5 ubiquitin specific peptidase 5 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:6,852,150...6,866,632
Ensembl chr12:6,852,148...6,866,632
JBrowse link
G VEGFA vascular endothelial growth factor A treatment EXP
IDA
CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:25231249 PMID:17784864 RGD:15003197 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
G VIM vimentin EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
JBrowse link
G VWF von Willebrand factor ISO
EXP
protein:increased expression:liver:
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:28527913 PMID:7531171 RGD:11079232 NCBI chr12:5,948,877...6,124,670
Ensembl chr12:5,948,877...6,124,770
JBrowse link
G WASL WASP like actin nucleation promoting factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:123,681,943...123,749,003
Ensembl chr 7:123,681,943...123,749,003
JBrowse link
G XRCC1 X-ray repair cross complementing 1 susceptibility ISO DNA:haploinsufficiency: : (mouse) RGD PMID:21737425 RGD:15036796 NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473
JBrowse link
G XYLB xylulokinase EXP CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 3:38,346,785...38,453,041
Ensembl chr 3:38,346,760...38,421,348
JBrowse link
G ZDHHC23 zinc finger DHHC-type palmitoyltransferase 23 EXP CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 3:113,947,901...113,979,508
Ensembl chr 3:113,947,901...113,965,401
JBrowse link
Chloramphenicol Toxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G MT-RNR2 mitochondrially encoded 16S rRNA IAGP ClinVar Annotator: match by term: Chloramphenicol resistance ClinVar PMID:6273808 PMID:7219548 NCBI chr MT:1,671...3,229
Ensembl chr MT:1,671...3,229
JBrowse link
drug allergy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20216337 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
JBrowse link
G ACE angiotensin I converting enzyme EXP CTD Direct Evidence: marker/mechanism CTD PMID:18727619 NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
JBrowse link
G ADORA1 adenosine A1 receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:19019667 NCBI chr 1:203,127,726...203,167,405
Ensembl chr 1:203,090,654...203,167,405
JBrowse link
G ADORA2A adenosine A2a receptor EXP CTD Direct Evidence: marker/mechanism CTD PMID:19019667 NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
JBrowse link
G CCL11 C-C motif chemokine ligand 11 EXP CTD Direct Evidence: marker/mechanism CTD PMID:14616128 NCBI chr17:34,285,742...34,288,334
Ensembl chr17:34,285,742...34,288,334
JBrowse link
G CCL24 C-C motif chemokine ligand 24 EXP CTD Direct Evidence: marker/mechanism CTD PMID:14616128 NCBI chr 7:75,810,825...75,823,372
Ensembl chr 7:75,810,825...75,823,356
JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
JBrowse link
G CYSLTR1 cysteinyl leukotriene receptor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16630147 NCBI chr  X:78,271,468...78,327,611
Ensembl chr  X:78,271,468...78,327,691
JBrowse link
G CYSLTR2 cysteinyl leukotriene receptor 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15970796 NCBI chr13:48,653,929...48,711,226
Ensembl chr13:48,653,711...48,711,226
JBrowse link
G FASLG Fas ligand EXP CTD Direct Evidence: marker/mechanism CTD PMID:19706026 NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
JBrowse link
G FCER1A Fc epsilon receptor Ia EXP CTD Direct Evidence: marker/mechanism CTD PMID:17125826 PMID:20485159 NCBI chr 1:159,283,575...159,308,202
Ensembl chr 1:159,289,714...159,308,224
JBrowse link
G FCER1G Fc epsilon receptor Ig EXP CTD Direct Evidence: marker/mechanism CTD PMID:18534082 PMID:18595682 NCBI chr 1:161,215,295...161,219,245
Ensembl chr 1:161,215,234...161,220,699
JBrowse link
G GSTM1 glutathione S-transferase mu 1 susceptibility IAGP
EXP
DNA:deletion: :
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:20485159 PMID:11007341 RGD:5491000 NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
JBrowse link
G GSTP1 glutathione S-transferase pi 1 susceptibility IAGP
EXP
associated with Acquired Immunodeficiency Syndrome;DNA:polymorphism:exon:A>G313 (rs1695) (human)
CTD Direct Evidence: marker/mechanism
CTD
RGD
PMID:20485159 PMID:16297214 RGD:5490995 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G GSTT1 glutathione S-transferase theta 1 susceptibility IAGP DNA:deletion: : RGD PMID:11007341 RGD:5491000
G GZMB granzyme B EXP CTD Direct Evidence: marker/mechanism CTD PMID:19706026 NCBI chr14:24,630,954...24,634,190
Ensembl chr14:24,630,954...24,634,267
JBrowse link
G HLA-B major histocompatibility complex, class I, B EXP CTD Direct Evidence: marker/mechanism CTD PMID:11943262 PMID:15024131 PMID:17392574 PMID:18007983 NCBI chr 6:31,353,875...31,357,179
Ensembl chr 6:31,353,872...31,367,067
JBrowse link
G HLA-DRB1 major histocompatibility complex, class II, DR beta 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
JBrowse link
G HNMT histamine N-methyltransferase EXP CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 2:137,964,473...138,016,364
Ensembl chr 2:137,964,020...138,016,364
JBrowse link
G HSPA1A heat shock protein family A (Hsp70) member 1A EXP CTD Direct Evidence: marker/mechanism CTD PMID:16538175 NCBI chr 6:31,815,543...31,817,942
Ensembl chr 6:31,815,543...31,817,946
JBrowse link
G HSPA1L heat shock protein family A (Hsp70) member 1 like EXP CTD Direct Evidence: marker/mechanism CTD PMID:16538175 NCBI chr 6:31,809,619...31,815,283
Ensembl chr 6:31,809,619...31,815,283
JBrowse link
G IL10 interleukin 10 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19222424 PMID:20485159 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL13 interleukin 13 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
JBrowse link
G IL2 interleukin 2 IDA RGD PMID:1549655 RGD:8662975 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G IL4 interleukin 4 EXP CTD Direct Evidence: marker/mechanism CTD PMID:15867870 PMID:20485159 NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
JBrowse link
G IL4R interleukin 4 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
JBrowse link
G LTC4S leukotriene C4 synthase EXP CTD Direct Evidence: marker/mechanism CTD PMID:16433794 NCBI chr 5:179,793,986...179,796,647
Ensembl chr 5:179,793,980...179,796,647
JBrowse link
G MLN motilin EXP CTD Direct Evidence: marker/mechanism CTD PMID:16538176 NCBI chr 6:33,794,673...33,804,003
Ensembl chr 6:33,794,673...33,804,003
JBrowse link
G MS4A2 membrane spanning 4-domains A2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:16839402 PMID:18534082 PMID:20485159 NCBI chr11:60,088,259...60,098,467
Ensembl chr11:60,088,261...60,098,467
JBrowse link
G NAT2 N-acetyltransferase 2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20485159 PMID:20602614 PMID:21572414 NCBI chr 8:18,386,301...18,401,218
Ensembl chr 8:18,391,282...18,401,218
JBrowse link
G NLRP3 NLR family pyrin domain containing 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19767079 NCBI chr 1:247,416,077...247,448,817
Ensembl chr 1:247,416,156...247,449,108
JBrowse link
G POSTN periostin EXP CTD Direct Evidence: marker/mechanism CTD PMID:18391768 NCBI chr13:37,562,585...37,598,768
Ensembl chr13:37,562,583...37,598,844
JBrowse link
G PTGER3 prostaglandin E receptor 3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:20587336 NCBI chr 1:70,852,358...71,047,816
Ensembl chr 1:70,852,353...71,047,816
JBrowse link
G PTGS1 prostaglandin-endoperoxide synthase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:17508966 NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
JBrowse link
G TAC1 tachykinin precursor 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21233199 NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
JBrowse link
G TBXAS1 thromboxane A synthase 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21449675 NCBI chr 7:139,778,242...140,020,293
Ensembl chr 7:139,777,051...140,020,325
JBrowse link
G TNF tumor necrosis factor EXP CTD Direct Evidence: marker/mechanism CTD PMID:11294926 PMID:20485159 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNFRSF10A TNF receptor superfamily member 10a EXP CTD Direct Evidence: marker/mechanism CTD PMID:19652058 NCBI chr 8:23,190,452...23,225,102
Ensembl chr 8:23,190,452...23,225,102
JBrowse link
Drug Eruptions term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX5 arachidonate 5-lipoxygenase EXP CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
JBrowse link
G APOA1 apolipoprotein A1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr11:116,835,751...116,837,950
Ensembl chr11:116,835,751...116,837,622
JBrowse link
G APOC2 apolipoprotein C2 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr19:44,946,051...44,949,565
Ensembl chr19:44,946,035...44,949,565
JBrowse link
G APOC3 apolipoprotein C3 EXP CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr11:116,829,907...116,833,072
Ensembl chr11:116,829,706...116,833,072
JBrowse link
G BDNF brain derived neurotrophic factor ISO mRNA:increased expression:lymph node, ear: RGD PMID:19904815 RGD:8657071 NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
JBrowse link
G C4B complement C4B (Chido/Rodgers blood group) EXP CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 6:32,014,795...32,035,418
Ensembl chr 6:32,014,795...32,035,418
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 susceptibility
treatment
IAGP DNA:SNP: :Rs4244285(human)
associated with tuberculosis; DNA.polymorphism, haplotype:cds:p.W212X (human)
RGD PMID:23551241 PMID:20941486 RGD:11352742, RGD:124713543 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 EXP CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220